Regulation	O
of	O
Id3	B-protein
cell	O
cycle	O
function	O
by	O
Cdk-2-dependent	O
phosphorylation	O
.	O

The	O
functions	O
of	O
basic	B-protein
helix-loop-helix	I-protein
(	I-protein
bHLH	I-protein
)	I-protein
transcription	I-protein
factors	I-protein
in	O
activating	O
differentiation-linked	O
gene	O
expression	O
and	O
in	O
inducing	O
G1	O
cell	O
cycle	O
arrest	O
are	O
negatively	O
regulated	O
by	O
members	O
of	O
the	O
Id	B-protein
family	I-protein
of	I-protein
HLH	I-protein
proteins	I-protein
.	O

These	O
bHLH	B-protein
antagonists	I-protein
are	O
induced	O
during	O
a	O
mitogenic	O
signalling	O
response	O
,	O
and	O
they	O
function	O
by	O
sequestering	O
their	O
bHLH	B-protein
targets	I-protein
in	O
inactive	B-protein
heterodimers	I-protein
that	O
are	O
unable	O
to	O
bind	O
to	O
specific	O
gene	B-DNA
regulatory	I-DNA
(	I-DNA
E	I-DNA
box	I-DNA
)	I-DNA
sequences	I-DNA
.	O

Recently	O
,	O
cyclin	O
E-Cdk2-	O
and	O
cyclin	O
A-Cdk2-dependent	O
phosphorylation	O
of	O
a	O
single	O
conserved	O
serine	O
residue	O
(	O
Ser5	O
)	O
in	O
Id2	B-protein
has	O
been	O
shown	O
to	O
occur	O
during	O
late	O
G1-to-S	O
phase	O
transition	O
of	O
the	O
cell	O
cycle	O
,	O
and	O
this	O
neutralizes	O
the	O
function	O
of	O
Id2	B-protein
in	O
abrogating	O
E-box-dependent	B-protein
bHLH	I-protein
homo	O
-or	O
heterodimer	O
complex	O
formation	O
in	O
vitro	O
(	O
E.Hara	O
,	O
M.Hall	O
,	O
and	O
G.Peters	O
,	O
EMBO	O
J.16	O
:	O
332-342	O
,	O
1997	O
)	O
.	O

We	O
now	O
show	O
that	O
an	O
analogous	O
cell-cycle-regulated	O
phosphorylation	O
of	O
Id3	B-protein
alters	O
the	O
specificity	O
of	O
Id3	B-protein
for	O
abrogating	O
both	O
E-box-dependent	B-protein
bHLH	I-protein
homo-	O
or	O
heterodimer	O
complex	O
formation	O
in	O
vitro	O
and	O
E-box-dependent	O
reporter	B-DNA
gene	I-DNA
function	O
in	O
vivo	O
.	O

Furthermore	O
,	O
compared	O
with	O
wild-type	B-protein
Id3	I-protein
,	O
an	O
Id3	B-protein
Asp5	I-protein
mutant	I-protein
(	O
mimicking	O
phosphorylation	O
)	O
is	O
unable	O
to	O
promote	O
cell	O
cycle	O
S	O
phase	O
entry	O
in	O
transfected	B-cell_line
fibroblasts	I-cell_line
,	O
whereas	O
an	O
Id3	B-protein
Ala5	I-protein
mutant	I-protein
(	O
ablating	O
phosphorylation	O
)	O
displays	O
an	O
activity	O
significantly	O
greater	O
than	O
that	O
of	O
wild-type	B-protein
Id3	I-protein
protein	I-protein
.	O

Cdk2-dependent	O
phosphorylation	O
therefore	O
provides	O
a	O
switch	O
during	O
late	O
G1-to-S	O
phase	O
that	O
both	O
nullifies	O
an	O
early	O
G1	O
cell	O
cycle	O
regulatory	O
function	O
of	O
Id3	B-protein
and	O
modulates	O
its	O
target	O
bHLH	B-protein
specificity	O
.	O

These	O
data	O
also	O
demonstrate	O
that	O
the	O
ability	O
of	O
Id3	B-protein
to	O
promote	O
cell	O
cycle	O
S	O
phase	O
entry	O
is	O
not	O
simply	O
a	O
function	O
of	O
its	O
ability	O
to	O
modulate	O
bHLH	B-protein
heterodimer-dependent	O
gene	O
expression	O
and	O
establish	O
a	O
biologically	O
important	O
mechanism	O
through	O
which	O
Cdk2	O
and	O
Id-bHLH	O
functions	O
are	O
integrated	O
in	O
the	O
coordination	O
of	O
cell	O
proliferation	O
and	O
differentiation	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Dec.	NULL
1997	NULL
,	NULL
p.	NULL
6815-6821	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

12	NULL
Regulation	NULL
of	NULL
Id3	NULL
Cell	NULL
Cycle	NULL
Function	NULL
by	NULL
Cdk-2-Dependent	NULL
Phosphorylation	NULL
RICHARD	NULL
W.	NULL
DEED	NULL
,	NULL
``	NULL
EIJI	NULL
HARA	NULL
,	NULL
``	NULL
GRAHAM	NULL
T.	NULL
ATHERTON	NULL
,	NULL
GORDON	NULL
PETERS	NULL
,	NULL
``	NULL
anp	NULL
JOHN	NULL
D	NULL
.	NULL

NORTON	NULL
!	NULL

'*	NULL
CRC	NULL
Department	NULL
of	NULL
Gene	NULL
Regulation	NULL
,	NULL
Paterson	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Christie	NULL
Hospital	NULL
NHS	NULL
Trust	NULL
,	NULL
Manchester	NULL
M20	NULL
9BX	NULL
,	NULL
``	NULL
and	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
Laboratories	NULL
,	NULL
London	NULL
WC2A	NULL
3PX	NULL
,	NULL
``	NULL
United	NULL
Kingdom	NULL
Received	NULL
28	NULL
March	NULL
1997/Returned	NULL
for	NULL
modification	NULL
10	NULL
June	NULL
1997/Accepted	NULL
4	NULL
September	NULL
1997	NULL
The	NULL
functions	NULL
of	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
transcription	NULL
factors	NULL
in	NULL
activating	NULL
differentiation-linked	NULL
gene	NULL
expression	NULL
and	NULL
in	NULL
inducing	NULL
G	NULL
,	NULL
cell	NULL
cycle	NULL
arrest	NULL
are	NULL
negatively	NULL
regulated	NULL
by	NULL
members	NULL
of	NULL
the	NULL
Id	NULL
family	NULL
of	NULL
HLH	NULL
proteins	NULL
.	NULL

These	NULL
bHLH	NULL
antagonists	NULL
are	NULL
induced	NULL
during	NULL
a	NULL
mitogenic	NULL
signalling	NULL
response	NULL
,	NULL
and	NULL
they	NULL
function	NULL
by	NULL
sequestering	NULL
their	NULL
bHLH	NULL
targets	NULL
in	NULL
inactive	NULL
heterodimers	NULL
that	NULL
are	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
specific	NULL
gene	NULL
regulatory	NULL
(	NULL
E	NULL
box	NULL
)	NULL
sequences	NULL
.	NULL

Recently	NULL
,	NULL
cyclin	NULL
E-Cdk2-	NULL
and	NULL
cyclin	NULL
A-Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
a	NULL
single	NULL
conserved	NULL
serine	NULL
residue	NULL
(	NULL
Ser5	NULL
)	NULL
in	NULL
Id2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
occur	NULL
during	NULL
late	NULL
G	NULL
;	NULL
-to-S	NULL
phase	NULL
transition	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
and	NULL
this	NULL
neutralizes	NULL
the	NULL
function	NULL
of	NULL
Id2	NULL
in	NULL
abrogating	NULL
E-box-dependent	NULL
bHLH	NULL
homo-	NULL
or	NULL
heterodimer	NULL
complex	NULL
formation	NULL
in	NULL
vitro	NULL
(	NULL
E.	NULL
Hara	NULL
,	NULL
M.	NULL
Hall	NULL
,	NULL
and	NULL
G.	NULL
Peters	NULL
,	NULL
EMBO	NULL
J	NULL
.	NULL

16:332-342	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
an	NULL
analogous	NULL
cell-cycle-regulated	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
alters	NULL
the	NULL
specificity	NULL
of	NULL
Id3	NULL
for	NULL
abrogating	NULL
both	NULL
E-box-dependent	NULL
bHLH	NULL
homo-	NULL
or	NULL
heterodimer	NULL
complex	NULL
formation	NULL
in	NULL
vitro	NULL
and	NULL
E-box-dependent	NULL
reporter	NULL
gene	NULL
function	NULL
in	NULL
vivo	NULL
.	NULL

Furthermore	NULL
,	NULL
compared	NULL
with	NULL
wild-type	NULL
Id3	NULL
,	NULL
an	NULL
Id3	NULL
Asp5	NULL
mutant	NULL
(	NULL
mimicking	NULL
phosphorylation	NULL
)	NULL
is	NULL
unable	NULL
to	NULL
promote	NULL
cell	NULL
cycle	NULL
S	NULL
phase	NULL
entry	NULL
in	NULL
transfected	NULL
fibroblasts	NULL
,	NULL
whereas	NULL
an	NULL
Id3	NULL
AlaS	NULL
mutant	NULL
(	NULL
ablating	NULL
phosphorylation	NULL
)	NULL
displays	NULL
an	NULL
activity	NULL
significantly	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
wild-type	NULL
Id3	NULL
protein	NULL
.	NULL

Cdk2-dependent	NULL
phosphorylation	NULL
therefore	NULL
provides	NULL
a	NULL
switch	NULL
during	NULL
late	NULL
G	NULL
,	NULL
-to-S	NULL
phase	NULL
that	NULL
both	NULL
nullifies	NULL
an	NULL
early	NULL
G	NULL
,	NULL
cell	NULL
cycle	NULL
regulatory	NULL
function	NULL
of	NULL
Id3	NULL
and	NULL
modulates	NULL
its	NULL
target	NULL
bHLH	NULL
specificity	NULL
.	NULL

These	NULL
data	NULL
also	NULL
demonstrate	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
Id3	NULL
to	NULL
promote	NULL
cell	NULL
cycle	NULL
S	NULL
phase	NULL
entry	NULL
is	NULL
not	NULL
simply	NULL
a	NULL
function	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
modulate	NULL
bHLH	NULL
heterodimer-dependent	NULL
gene	NULL
expression	NULL
and	NULL
establish	NULL
a	NULL
biologically	NULL
important	NULL
mechanism	NULL
through	NULL
which	NULL
Cdk2	NULL
and	NULL
Id-bHLH	NULL
functions	NULL
are	NULL
integrated	NULL
in	NULL
the	NULL
coordination	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

Transcription	NULL
factors	NULL
characterized	NULL
by	NULL
the	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
domain	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
(	NULL
24	NULL
,	NULL
30	NULL
)	NULL
.	NULL

DNA	NULL
binding	NULL
of	NULL
bHLH	NULL
proteins	NULL
to	NULL
a	NULL
consensus	NULL
E	NULL
box	NULL
recognition	NULL
sequence	NULL
(	NULL
CANNTG	NULL
)	NULL
is	NULL
facilitated	NULL
by	NULL
the	NULL
basic	NULL
region	NULL
located	NULL
immediately	NULL
N-terminal	NULL
to	NULL
the	NULL
two	NULL
amphipathic	NULL
alpha	NULL
helices	NULL
encompassing	NULL
the	NULL
loop	NULL
region	NULL
,	NULL
which	NULL
together	NULL
comprise	NULL
the	NULL
highly	NULL
conserved	NULL
HLH	NULL
domain	NULL
(	NULL
24	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
HLH	NULL
domain	NULL
itself	NULL
mediates	NULL
dimerization	NULL
,	NULL
which	NULL
is	NULL
essential	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
of	NULL
target	NULL
genes	NULL
that	NULL
are	NULL
typically	NULL
involved	NULL
in	NULL
driving	NULL
cell	NULL
lineage	NULL
commitment	NULL
and	NULL
terminal	NULL
differentiation	NULL
(	NULL
24	NULL
,	NULL
30	NULL
,	NULL
34	NULL
)	NULL
.	NULL

There	NULL
are	NULL
two	NULL
distinct	NULL
classes	NULL
of	NULL
bHLH	NULL
proteins	NULL
(	NULL
18	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Class	NULL
A	NULL
bHLH	NULL
proteins	NULL
,	NULL
exemplified	NULL
by	NULL
the	NULL
E2A-encoded	NULL
E12	NULL
,	NULL
E47	NULL
,	NULL
and	NULL
E2-5/ITF	NULL
proteins	NULL
(	NULL
14	NULL
,	NULL
31	NULL
)	NULL
,	NULL
often	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
``	NULL
E	NULL
``	NULL
proteins	NULL
,	NULL
are	NULL
ubiquitously	NULL
expressed	NULL
,	NULL
whereas	NULL
the	NULL
class	NULL
B	NULL
subset	NULL
represents	NULL
a	NULL
rather	NULL
larger	NULL
collection	NULL
of	NULL
more-tissue-specific	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
MyoD	NULL
(	NULL
and	NULL
its	NULL
myogenic	NULL
relatives	NULL
)	NULL
in	NULL
muscle	NULL
cells	NULL
(	NULL
32	NULL
,	NULL
36	NULL
,	NULL
42	NULL
)	NULL
,	NULL
TAL1/	NULL
LYL-1	NULL
in	NULL
hemopoietic	NULL
cells	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
NeuroD	NULL
in	NULL
neuronal	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Although	NULL
homodimers	NULL
of	NULL
class	NULL
A	NULL
bHLH	NULL
proteins	NULL
are	NULL
known	NULL
to	NULL
be	NULL
functional	NULL
,	NULL
most	NULL
notably	NULL
in	NULL
the	NULL
B-lymphocyte	NULL
lineage	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
44	NULL
)	NULL
,	NULL
the	NULL
more	NULL
usual	NULL
configuration	NULL
for	NULL
E	NULL
box	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
CRC	NULL
Department	NULL
of	NULL
Gene	NULL
Regulation	NULL
,	NULL
Paterson	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Christie	NULL
Hospital	NULL
NHS	NULL
Trust	NULL
,	NULL
Wilmslow	NULL
Rd	NULL
.	NULL

,	NULL
Manchester	NULL
M20	NULL
9BX	NULL
,	NULL
United	NULL
Kingdom	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
44	NULL
)	NULL
161	NULL
446	NULL
3129	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
44	NULL
)	NULL
161	NULL
446	NULL
3109	NULL
.	NULL

E-mail	NULL
:	NULL
grgjdn	NULL
@	NULL
picr.cr.man.ac.uk	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Preventive	NULL
Medicine	NULL
,	NULL
Kyoto	NULL
Pre-fectural	NULL
University	NULL
of	NULL
Medicine	NULL
,	NULL
Kawaramachi-Hirokohi	NULL
,	NULL
Kamigyo-ku	NULL
,	NULL
Kyoto	NULL
602	NULL
,	NULL
Japan	NULL
.	NULL

6815	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
is	NULL
a	NULL
class	NULL
A-class	NULL
B	NULL
bHLH	NULL
heterodimer	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
bHLH	NULL
proteins	NULL
are	NULL
regulated	NULL
through	NULL
a	NULL
variety	NULL
of	NULL
mechanisms	NULL
,	NULL
one	NULL
of	NULL
which	NULL
involves	NULL
heterodimerization	NULL
with	NULL
members	NULL
of	NULL
the	NULL
Id	NULL
family	NULL
of	NULL
HLH	NULL
proteins	NULL
(	NULL
6	NULL
)	NULL
.	NULL

This	NULL
distinct	NULL
class	NULL
of	NULL
HLH	NULL
protein	NULL
,	NULL
of	NULL
which	NULL
there	NULL
are	NULL
four	NULL
members	NULL
in	NULL
mammals	NULL
(	NULL
Id1	NULL
to	NULL
Id4	NULL
)	NULL
(	NULL
24	NULL
)	NULL
,	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
basic	NULL
DNA-binding	NULL
domain	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
Id	NULL
proteins	NULL
are	NULL
able	NULL
to	NULL
antagonize	NULL
the	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
functions	NULL
of	NULL
bHLH	NULL
transcription	NULL
factors	NULL
through	NULL
heterodimerization	NULL
(	NULL
6	NULL
,	NULL
24	NULL
)	NULL
,	NULL
a	NULL
process	NULL
which	NULL
also	NULL
results	NULL
in	NULL
destabilization	NULL
of	NULL
the	NULL
bHLH	NULL
protein	NULL
partner	NULL
(	NULL
8	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
enforced	NULL
ectopic	NULL
expression	NULL
of	NULL
Id	NULL
genes	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
lineages	NULL
can	NULL
promote	NULL
cell	NULL
growth	NULL
and	NULL
inhibit	NULL
differentiation	NULL
,	NULL
and	NULL
this	NULL
is	NULL
typically	NULL
manifested	NULL
in	NULL
a	NULL
delayed	NULL
exit	NULL
from	NULL
the	NULL
cell	NULL
cycle	NULL
under	NULL
differentiation-inducing	NULL
conditions	NULL
(	NULL
1	NULL
,	NULL
10	NULL
,	NULL
17	NULL
,	NULL
37	NULL
,	NULL
41	NULL
)	NULL
.	NULL

These	NULL
functional	NULL
properties	NULL
of	NULL
Id	NULL
proteins	NULL
exactly	NULL
mirror	NULL
those	NULL
of	NULL
their	NULL
bHLH	NULL
counterparts	NULL
,	NULL
which	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
driving	NULL
differentiation-linked	NULL
gene	NULL
expression	NULL
,	NULL
also	NULL
function	NULL
to	NULL
inhibit	NULL
cell	NULL
proliferation	NULL
,	NULL
principally	NULL
through	NULL
an	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
7	NULL
,	NULL
33	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Significantly	NULL
,	NULL
Id	NULL
gene	NULL
and	NULL
protein	NULL
expression	NULL
is	NULL
markedly	NULL
up-regulated	NULL
during	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
transition	NULL
in	NULL
response	NULL
to	NULL
mitogenic	NULL
stimulation	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
13	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
antisense	NULL
oligonucleotide	NULL
blockade	NULL
and	NULL
antibody	NULL
microinjection	NULL
experiments	NULL
have	NULL
suggested	NULL
a	NULL
requirement	NULL
of	NULL
Id	NULL
function	NULL
for	NULL
entry	NULL
of	NULL
cells	NULL
into	NULL
S	NULL
phase	NULL
(	NULL
4	NULL
,	NULL
13	NULL
,	NULL
33	NULL
)	NULL
.	NULL

A	NULL
widely	NULL
held	NULL
view	NULL
is	NULL
that	NULL
the	NULL
opposing	NULL
activities	NULL
of	NULL
bHLH	NULL
and	NULL
Id	NULL
proteins	NULL
represent	NULL
a	NULL
major	NULL
control	NULL
mechanism	NULL
for	NULL
determining	NULL
cell	NULL
fate	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
potential	NULL
link	NULL
has	NULL
been	NULL
established	NULL
between	NULL
the	NULL
activities	NULL
of	NULL
Id-bHLH	NULL
proteins	NULL
and	NULL
cell	NULL
cycle	NULL
regulation	NULL
by	NULL
the	NULL
demonstration	NULL
that	NULL
the	NULL
Id2	NULL
protein	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
cyclin	NULL
E	NULL
6816	NULL
DEED	NULL
ET	NULL
AL	NULL
.	NULL

and	NULL
cyclin	NULL
A-dependent	NULL
Cdk2	NULL
activity	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
a	NULL
serine	NULL
residue	NULL
at	NULL
position	NULL
5	NULL
in	NULL
Id2	NULL
abolishes	NULL
its	NULL
ability	NULL
to	NULL
antagonize	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
model	NULL
E12-MyoD-E-box-binding	NULL
complex	NULL
in	NULL
in	NULL
vitro	NULL
band	NULL
shift	NULL
assays	NULL
.	NULL

Moreover	NULL
,	NULL
following	NULL
mitogenic	NULL
stimulation	NULL
in	NULL
vivo	NULL
,	NULL
phosphorylation	NULL
of	NULL
Id2	NULL
at	NULL
serine	NULL
5	NULL
occurs	NULL
during	NULL
late	NULL
G	NULL
,	NULL
,	NULL
at	NULL
a	NULL
time	NULL
which	NULL
correlates	NULL
both	NULL
with	NULL
activation	NULL
of	NULL
cyclin	NULL
E-Cdk2	NULL
and	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
specific	NULL
E	NULL
box	NULL
DNA-binding	NULL
complex	NULL
in	NULL
vivo	NULL
that	NULL
can	NULL
be	NULL
abrogated	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unphosphorylated	NULL
Id2	NULL
protein	NULL
(	NULL
12	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggested	NULL
that	NULL
Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
Id	NULL
proteins	NULL
might	NULL
alter	NULL
their	NULL
target	NULL
specificities	NULL
and	NULL
that	NULL
this	NULL
might	NULL
represent	NULL
an	NULL
important	NULL
mechanism	NULL
for	NULL
modulating	NULL
Id-bHLH	NULL
functions	NULL
in	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

We	NULL
have	NULL
now	NULL
confirmed	NULL
both	NULL
of	NULL
these	NULL
predictions	NULL
with	NULL
respect	NULL
to	NULL
Id3	NULL
,	NULL
the	NULL
only	NULL
other	NULL
well-characterized	NULL
Id	NULL
family	NULL
member	NULL
that	NULL
possesses	NULL
the	NULL
conserved	NULL
consensus	NULL
Cdk	NULL
phosphorylation	NULL
site	NULL
at	NULL
serine	NULL
5	NULL
.	NULL

Like	NULL
Id2	NULL
,	NULL
the	NULL
Id3	NULL
protein	NULL
becomes	NULL
phosphorylated	NULL
in	NULL
late	NULL
G	NULL
,	NULL
,	NULL
at	NULL
a	NULL
time	NULL
coincident	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
cyclin	NULL
A-	NULL
and	NULL
cyclin	NULL
E-dependent	NULL
Cdk2	NULL
.	NULL

In	NULL
vitro	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
by	NULL
Cdk2	NULL
abolishes	NULL
its	NULL
ability	NULL
to	NULL
antagonize	NULL
E12	NULL
homodimer	NULL
binding	NULL
to	NULL
an	NULL
E	NULL
box	NULL
sequence	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
Id2	NULL
,	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
greatly	NULL
enhances	NULL
its	NULL
ability	NULL
to	NULL
abrogate	NULL
E12-MyoD-E	NULL
box	NULL
complex	NULL
formation	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
substitution	NULL
of	NULL
a	NULL
highly	NULL
charged	NULL
aspartate	NULL
residue	NULL
at	NULL
serine	NULL
5	NULL
(	NULL
mimicking	NULL
phosphorylation	NULL
)	NULL
similarly	NULL
enhances	NULL
its	NULL
ability	NULL
to	NULL
inhibit	NULL
E12-MyoD	NULL
transactivation	NULL
of	NULL
an	NULL
E-box-dependent	NULL
reporter	NULL
gene	NULL
in	NULL
vivo	NULL
.	NULL

However	NULL
,	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
protein	NULL
,	NULL
AspS	NULL
Id3	NULL
is	NULL
completely	NULL
devoid	NULL
of	NULL
activity	NULL
in	NULL
promoting	NULL
S	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
in	NULL
transfected	NULL
fibroblasts	NULL
,	NULL
whereas	NULL
an	NULL
Ala5s	NULL
mutant	NULL
Id3	NULL
(	NULL
ablating	NULL
phosphorylation	NULL
)	NULL
displays	NULL
an	NULL
activity	NULL
significantly	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
protein	NULL
.	NULL

Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
during	NULL
late	NULL
G	NULL
,	NULL
therefore	NULL
nullifies	NULL
a	NULL
cell	NULL
cycle	NULL
regulatory	NULL
function	NULL
of	NULL
this	NULL
Id	NULL
protein	NULL
which	NULL
is	NULL
known	NULL
to	NULL
be	NULL
required	NULL
during	NULL
early	NULL
G	NULL
,	NULL
.	NULL

Our	NULL
findings	NULL
also	NULL
demonstrate	NULL
that	NULL
by	NULL
analogy	NULL
with	NULL
their	NULL
bHLH	NULL
counterparts	NULL
(	NULL
7	NULL
,	NULL
33	NULL
,	NULL
40	NULL
)	NULL
,	NULL
the	NULL
cell	NULL
cycle	NULL
regulatory	NULL
functions	NULL
of	NULL
Id	NULL
proteins	NULL
in	NULL
promoting	NULL
S	NULL
phase	NULL
may	NULL
be	NULL
dissociable	NULL
from	NULL
their	NULL
ability	NULL
to	NULL
modulate	NULL
bHLH	NULL
heterodimer-dependent	NULL
gene	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Purification	NULL
of	NULL
bacterially	NULL
expressed	NULL
Id	NULL
proteins	NULL
.	NULL

The	NULL
human	NULL
Id1	NULL
,	NULL
Id2	NULL
(	NULL
13	NULL
)	NULL
,	NULL
and	NULL
Id3	NULL
(	NULL
9	NULL
)	NULL
coding	NULL
sequences	NULL
and	NULL
their	NULL
various	NULL
mutants	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
pGEX-2T	NULL
vector	NULL
(	NULL
Pharmacia	NULL
)	NULL
or	NULL
the	NULL
pRSET-B	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
for	NULL
expression	NULL
in	NULL
bacteria	NULL
.	NULL

The	NULL
recombinant	NULL
proteins	NULL
were	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
pLysS	NULL
.	NULL

Glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-Id	NULL
proteins	NULL
were	NULL
purified	NULL
according	NULL
to	NULL
published	NULL
protocols	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Histidine-tagged	NULL
Id	NULL
proteins	NULL
produced	NULL
in	NULL
the	NULL
pRSET-B	NULL
vector	NULL
were	NULL
purified	NULL
on	NULL
nickel-charged	NULL
chelating	NULL
agarose	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
supplier	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
kinase	NULL
assays	NULL
.	NULL

In	NULL
vitro	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
Sf9	NULL
insect	NULL
cells	NULL
were	NULL
coinfected	NULL
with	NULL
the	NULL
appropriate	NULL
recombinant	NULL
baculoviruses	NULL
,	NULL
and	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
48	NULL
h	NULL
postinfection	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Phosphorylation	NULL
reactions	NULL
(	NULL
final	NULL
vol-ume	NULL
,	NULL
40	NULL
pl	NULL
)	NULL
were	NULL
performed	NULL
in	NULL
a	NULL
solution	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
100	NULL
mM	NULL
ATP	NULL
,	NULL
and	NULL
5	NULL
wCi	NULL
of	NULL
[	NULL
y-*°P	NULL
]	NULL
ATP	NULL
and	NULL
incubated	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
GST-Id1	NULL
,	NULL
GST-Id2	NULL
,	NULL
or	NULL
GST-Id3	NULL
bound	NULL
to	NULL
glutathione-Sepharose	NULL
beads	NULL
.	NULL

After	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
reactions	NULL
were	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
an	NULL
ice-cold	NULL
buffer	NULL
,	NULL
NETN	NULL
,	NULL
containing	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

The	NULL
glutathione-Sepharose	NULL
beads	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
several	NULL
times	NULL
in	NULL
NETN	NULL
,	NULL
boiled	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
with	NULL
a	NULL
12	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
Sf9	NULL
cell	NULL
lysates	NULL
were	NULL
preincubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
30°C	NULL
with	NULL
20	NULL
ng	NULL
of	NULL
histidine-tagged	NULL
p21	NULL
protein	NULL
.	NULL

Phosphate	NULL
labelling	NULL
and	NULL
immunoprecipitation	NULL
.	NULL

Primary	NULL
human	NULL
B	NULL
cells	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
29	NULL
)	NULL
and	NULL
were	NULL
rested	NULL
overnight	NULL
in	NULL
medium	NULL
(	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
[	NULL
FCS	NULL
]	NULL
)	NULL
.	NULL

Phorbol	NULL
ester	NULL
(	NULL
PMA	NULL
)	NULL
was	NULL
then	NULL
added	NULL
to	NULL
30	NULL
nM	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
labelled	NULL
with	NULL
0.5	NULL
mCi	NULL
of	NULL
[	NULL
**P	NULL
phate	NULL
per	NULL
ml	NULL
for	NULL
2	NULL
h	NULL
prior	NULL
to	NULL
harvest	NULL
at	NULL
various	NULL
times	NULL
poststimulation	NULL
.	NULL

Parallel	NULL
cultures	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
labelled	NULL
with	NULL
[	NULL
*°SJmethionine	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Labelled	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
Id3	NULL
protein	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
radicimmunopre-cipitation	NULL
assay	NULL
lysates	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

P-40	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
0.5	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
)	NULL
with	NULL
RD-1	NULL
polyclonal	NULL
anti-Id3	NULL
antibody	NULL
for	NULL
analysis	NULL
on	NULL
SDS-12	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
8	NULL
)	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
,	NULL
labelled	NULL
lysates	NULL
were	NULL
similarly	NULL
prepared	NULL
from	NULL
transiently	NULL
transfected	NULL
COS	NULL
cells	NULL
and	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
of	NULL
Id3	NULL
.	NULL

Expression	NULL
constructs	NULL
(	NULL
8	NULL
)	NULL
encoding	NULL
wild-type	NULL
Id3	NULL
and	NULL
Id3	NULL
AlaS	NULL
and	NULL
Asp§5	NULL
mutants	NULL
were	NULL
in	NULL
the	NULL
pcDNA3	NULL
expression	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
,	NULL
as	NULL
were	NULL
expression	NULL
constructs	NULL
encoding	NULL
cyclin	NULL
E	NULL
,	NULL
CdK2	NULL
,	NULL
p16	NULL
,	NULL
and	NULL
p21	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

Unlabelled	NULL
proteins	NULL
were	NULL
synthesized	NULL
by	NULL
coupled	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
plasmid	NULL
DNA	NULL
by	NULL
using	NULL
the	NULL
TNT	NULL
expression	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
with	NULL
either	NULL
T7	NULL
or	NULL
SP6	NULL
RNA	NULL
polymerase	NULL
.	NULL

Samples	NULL
(	NULL
5	NULL
wl	NULL
)	NULL
of	NULL
the	NULL
different	NULL
translation	NULL
reaction	NULL
mixtures	NULL
were	NULL
mixed	NULL
and	NULL
used	NULL
for	NULL
DNA-binding	NULL
assays	NULL
.	NULL

An	NULL
E	NULL
box	NULL
consensus	NULL
oligonucleotide	NULL
based	NULL
on	NULL
the	NULL
muscle	NULL
creatine	NULL
kinase	NULL
gene	NULL
enhancer	NULL
was	NULL
used	NULL
in	NULL
all	NULL
band	NULL
shift	NULL
assays	NULL
(	NULL
12	NULL
)	NULL
.	NULL

This	NULL
was	NULL
°°P	NULL
labelled	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
E.	NULL
coli	NULL
DNA	NULL
polymerase	NULL
I	NULL
and	NULL
was	NULL
used	NULL
in	NULL
conjunction	NULL
with	NULL
a	NULL
mutant	NULL
unlabelled	NULL
oligonucleotide	NULL
competitor	NULL
in	NULL
some	NULL
experiments	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

DNA-binding	NULL
reactions	NULL
were	NULL
done	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
comprising	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7	NULL
)	NULL
,	NULL
500	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
double-stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
0.2	NULL
ng	NULL
of	NULL
labelled	NULL
double-stranded	NULL
probe	NULL
.	NULL

The	NULL
mixtures	NULL
were	NULL
preincubated	NULL
without	NULL
the	NULL
labelled	NULL
probe	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
and	NULL
for	NULL
15	NULL
min	NULL
further	NULL
at	NULL
room	NULL
temperature	NULL
after	NULL
addition	NULL
of	NULL
the	NULL
labelled	NULL
probe	NULL
.	NULL

The	NULL
concentrations	NULL
and	NULL
purities	NULL
of	NULL
bacterially	NULL
expressed	NULL
(	NULL
histidine-tagged	NULL
)	NULL
Id	NULL
proteins	NULL
used	NULL
in	NULL
various	NULL
experiments	NULL
were	NULL
verified	NULL
by	NULL
PAGE	NULL
using	NULL
Coomassic	NULL
blue	NULL
staining	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
25	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
-25	NULL
mM	NULL
boric	NULL
acid-0.5	NULL
mM	NULL
EDTA	NULL
at	NULL
150	NULL
V	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
,	NULL
and	NULL
labelled	NULL
complexes	NULL
were	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

Analysis	NULL
of	NULL
gene	NULL
regulatory	NULL
and	NULL
cell	NULL
cycle	NULL
functions	NULL
of	NULL
Id3	NULL
.	NULL

Mouse	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
procedure	NULL
with	NULL
an	NULL
E-box-driven	NULL
chloramphenicol	NULL
acetylase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
cassette	NULL
together	NULL
with	NULL
E12	NULL
and	NULL
MyoD	NULL
expression	NULL
vectors	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
was	NULL
challenged	NULL
with	NULL
increasing	NULL
inputs	NULL
of	NULL
either	NULL
wild-type	NULL
or	NULL
mutant	NULL
Id	NULL
expression	NULL
constructs	NULL
,	NULL
and	NULL
all	NULL
transfections	NULL
were	NULL
normalized	NULL
for	NULL
efficiency	NULL
by	NULL
inclusion	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
.	NULL

Quantitation	NULL
of	NULL
CAT	NULL
and	NULL
luciferase	NULL
activity	NULL
in	NULL
cells	NULL
at	NULL
24	NULL
h	NULL
posttransfection	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
two-hybrid	NULL
luciferase	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
,	NULL
except	NULL
that	NULL
a	NULL
dual	NULL
luciferase	NULL
reporter	NULL
system	NULL
(	NULL
Stop	NULL
and	NULL
Glo	NULL
Lucif-erase	NULL
;	NULL
Promega	NULL
)	NULL
was	NULL
used	NULL
to	NULL
facilitate	NULL
monitoring	NULL
of	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
plasmids	NULL
encoding	NULL
Vp16MyoD	NULL
and	NULL
Gal4E12	NULL
were	NULL
constructed	NULL
by	NULL
insertion	NULL
of	NULL
mouse	NULL
MyoD	NULL
and	NULL
human	NULL
E12	NULL
cDNAs	NULL
,	NULL
modified	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
BamHI	NULL
recognition	NULL
site	NULL
at	NULL
the	NULL
ATG	NULL
start	NULL
site	NULL
,	NULL
into	NULL
BamHI/EcoRI-digested	NULL
pVp16	NULL
Neo	NULL
!	NULL

and	NULL
Psg	NULL
424	NULL
vectors	NULL
,	NULL
respectively	NULL
(	NULL
8	NULL
)	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
Id3	NULL
effects	NULL
on	NULL
cell	NULL
proliferation	NULL
,	NULL
primary	NULL
rat	NULL
embryo	NULL
fibroblasts	NULL
(	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
as	NULL
above	NULL
.	NULL

The	NULL
LacZ-expressing	NULL
vector	NULL
pCMVBGal	NULL
(	NULL
1	NULL
)	NULL
was	NULL
included	NULL
as	NULL
a	NULL
marker	NULL
to	NULL
permit	NULL
immunofluorescent	NULL
detection	NULL
of	NULL
transfected	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
pulse	NULL
labelled	NULL
with	NULL
10	NULL
nM	NULL
bromodeoxyuridine	NULL
(	NULL
BrdU	NULL
)	NULL
for	NULL
4	NULL
h	NULL
and	NULL
then	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
fixed	NULL
with	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
.	NULL

After	NULL
per-meabilization	NULL
in	NULL
0.2	NULL
%	NULL
Triton	NULL
X-100	NULL
(	NULL
15	NULL
min	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
1/500	NULL
dilution	NULL
of	NULL
anti-LacZ	NULL
antibody	NULL
(	NULL
5	NULL
Prime-3	NULL
Prime	NULL
,	NULL
Boulder	NULL
,	NULL
Colo.	NULL
)	NULL
overnight	NULL
at	NULL
4°C	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
a	NULL
1/100	NULL
dilution	NULL
of	NULL
biotin-labelled	NULL
anti-rabbit	NULL
antibody	NULL
(	NULL
Dako	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
1	NULL
h.	NULL
A	NULL
1/40	NULL
dilution	NULL
of	NULL
strepta-vidin-fluorescein	NULL
isothiocyanate	NULL
(	NULL
Dako	NULL
)	NULL
was	NULL
used	NULL
for	NULL
immunofluorescent	NULL
detection	NULL
of	NULL
LacZ-expressing	NULL
cells	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
incorporated	NULL
BrdU	NULL
,	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
2	NULL
M	NULL
HCI	NULL
for	NULL
20	NULL
min	NULL
,	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
a	NULL
1/10	NULL
dilution	NULL
of	NULL
monoclonal	NULL
antibody	NULL
to	NULL
BrdU	NULL
for	NULL
30	NULL
min	NULL
,	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
the	NULL
supplier	NULL
(	NULL
Boehringer	NULL
)	NULL
.	NULL

After	NULL
a	NULL
wash	NULL
in	NULL
PBS	NULL
,	NULL
a	NULL
direct	NULL
Texas	NULL
red	NULL
conjugate	NULL
of	NULL
secondary	NULL
anti-mouse	NULL
antibody	NULL
was	NULL
used	NULL
at	NULL
a	NULL
1/40	NULL
dilution	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
transfected	NULL
Id	NULL
protein	NULL
was	NULL
monitored	NULL
by	NULL
immunofluorescent	NULL
staining	NULL
in	NULL
these	NULL
experiments	NULL
,	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
.	NULL

RESULTS	NULL
Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
in	NULL
vitro	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
Id3	NULL
could	NULL
be	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
cyclin-Cdk2	NULL
complexes	NULL
,	NULL
bacterially	NULL
expressed	NULL
Id	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
cell	NULL
extracts	NULL
from	NULL
baculovirus-infected	NULL
Sf9	NULL
cells	NULL
expressing	NULL
combinations	NULL
of	NULL
cyclins	NULL
and	NULL
Cdk	NULL
's	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
the	NULL
Id1	NULL
protein	NULL
,	NULL
which	NULL
lacks	NULL
a	NULL
consensus	NULL
Cdk	NULL
site	NULL
,	NULL
was	NULL
not	NULL
detectably	NULL
phosphorylated	NULL
by	NULL
any	NULL
of	NULL
the	NULL
combinations	NULL
of	NULL
cyclins	NULL
or	NULL
Cdk	NULL
's	NULL
used	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
data	NULL
(	NULL
12	NULL
)	NULL
,	NULL
Id2	NULL
was	NULL
phosphorylatable	NULL
by	NULL
cyclin	NULL
A-	NULL
and	NULL
E-Cdk2	NULL
but	NULL
not	NULL
by	NULL
cyclin	NULL
D-Cdk4	NULL
,	NULL
and	NULL
the	NULL
same	NULL
profile	NULL
was	NULL
displayed	NULL
by	NULL
the	NULL
Id3	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
cyclin	NULL
A-Cdk2	NULL
appeared	NULL
to	NULL
phosphor-ylate	NULL
Id3	NULL
more	NULL
efficiently	NULL
than	NULL
did	NULL
cyclin	NULL
E-Cdk2	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
assays	NULL
(	NULL
compare	NULL
the	NULL
profiles	NULL
of	NULL
Id2	NULL
and	NULL
Id3	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
of	NULL
substrate	NULL
specificity	NULL
of	NULL
these	NULL
Cdk2	NULL
complexes	NULL
for	NULL
Id3	NULL
.	NULL

Cyclin	NULL
A-	NULL
and	NULL
E-Cdk2	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
was	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
Id3Wt	NULL
Id3Ala5	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

In	NULL
vitro	NULL
phosphorylation	NULL
of	NULL
Id	NULL
proteins	NULL
by	NULL
cyclin-Cdk2	NULL
complexes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sf9	NULL
insect	NULL
cells	NULL
were	NULL
coinfected	NULL
with	NULL
baculovirus	NULL
vectors	NULL
encoding	NULL
the	NULL
appropriate	NULL
cyclins	NULL
and	NULL
Cdk	NULL
's	NULL
in	NULL
order	NULL
to	NULL
assemble	NULL
functional	NULL
complexes	NULL
in	NULL
vivo	NULL
.	NULL

Lysates	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
relevant	NULL
GST-Id	NULL
protein	NULL
together	NULL
with	NULL
[	NULL
y-P	NULL
]	NULL
JATP	NULL
.	NULL

Control	NULL
lysates	NULL
were	NULL
from	NULL
uninfected	NULL
S9	NULL
cells	NULL
.	NULL

The	NULL
resulting	NULL
labelled	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
with	NULL
a	NULL
12	NULL
%	NULL
acrylamide	NULL
gel	NULL
.	NULL

(	NULL
B	NULL
)	NULL
A	NULL
histidine-tagged	NULL
Id3	NULL
protein	NULL
,	NULL
either	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
Wt	NULL
)	NULL
or	NULL
having	NULL
a	NULL
mutation	NULL
at	NULL
serine	NULL
5	NULL
(	NULL
SerS-Ala5	NULL
)	NULL
,	NULL
was	NULL
used	NULL
for	NULL
the	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Cdk2	NULL
inhibitor	NULL
,	NULL
p21	NULL
(	NULL
expressed	NULL
as	NULL
a	NULL
His-tagged	NULL
fusion	NULL
protein	NULL
)	NULL
.	NULL

completely	NULL
abolished	NULL
by	NULL
the	NULL
Cdk	NULL
inhibitor	NULL
,	NULL
p21	NULL
,	NULL
and	NULL
also	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
Id3	NULL
at	NULL
serine	NULL
5	NULL
(	NULL
SerS-Ala5	NULL
)	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
in	NULL
vivo	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
occurs	NULL
in	NULL
vivo	NULL
,	NULL
primary	NULL
human	NULL
B	NULL
cells	NULL
were	NULL
used	NULL
,	NULL
since	NULL
this	NULL
cell	NULL
type	NULL
expresses	NULL
particularly	NULL
abundant	NULL
levels	NULL
of	NULL
Id3	NULL
protein	NULL
.	NULL

Following	NULL
mitogenic	NULL
stimulation	NULL
,	NULL
a	NULL
transient	NULL
peak	NULL
of	NULL
Id3	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
labelling	NULL
at	NULL
around	NULL
4	NULL
h	NULL
poststimulation	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

This	NULL
had	NULL
declined	NULL
by	NULL
16	NULL
h	NULL
and	NULL
was	NULL
upregulated	NULL
at	NULL
24	NULL
h	NULL
,	NULL
around	NULL
the	NULL
time	NULL
of	NULL
transition	NULL
from	NULL
G	NULL
;	NULL
,	NULL
to	NULL
S	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
°°P-labelled	NULL
Id3	NULL
was	NULL
immunoprecipitable	NULL
only	NULL
at	NULL
these	NULL
later	NULL
time	NULL
points	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
which	NULL
coincided	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
cyclin	NULL
A-	NULL
and	NULL
E-Cdk2	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
kinetics	NULL
of	NULL
Id3	NULL
phosphorylation	NULL
therefore	NULL
appear	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
those	NULL
previously	NULL
reported	NULL
for	NULL
Id2	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
when	NULL
expression	NULL
constructs	NULL
encoding	NULL
either	NULL
wild-type	NULL
Id3	NULL
or	NULL
the	NULL
Ala5	NULL
mutant	NULL
of	NULL
Id3	NULL
were	NULL
transfected	NULL
into	NULL
COS	NULL
cells	NULL
,	NULL
only	NULL
the	NULL
wild-type	NULL
protein	NULL
was	NULL
°°P	NULL
labelled	NULL
,	NULL
whereas	NULL
both	NULL
mutant	NULL
and	NULL
wild-type	NULL
proteins	NULL
were	NULL
[	NULL
**S	NULL
)	NULL
methionine	NULL
labelled	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Phosphorylation	NULL
was	NULL
specifically	NULL
abrogated	NULL
by	NULL
the	NULL
Cdk	NULL
inhibitor	NULL
,	NULL
p21	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
p16	NULL
,	NULL
which	NULL
specifically	NULL
targets	NULL
Cdk4	NULL
and	NULL
Cdk6	NULL
.	NULL

Essentially	NULL
all	NULL
of	NULL
the	NULL
in	NULL
vivo-phosphorylated	NULL
Id3	NULL
can	NULL
therefore	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
cyclin	NULL
E-and	NULL
A-Cdk2	NULL
phosphorylation	NULL
of	NULL
the	NULL
serine	NULL
5	NULL
residue	NULL
.	NULL

Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
affects	NULL
bHLH	NULL
antagonism	NULL
in	NULL
vitro	NULL
.	NULL

Previously	NULL
,	NULL
phosphorylation	NULL
of	NULL
Id2	NULL
by	NULL
cyclin	NULL
A-	NULL
and	NULL
E-Cdk2	NULL
was	NULL
shown	NULL
to	NULL
completely	NULL
abrogate	NULL
its	NULL
ability	NULL
to	NULL
antagonize	NULL
bHLH	NULL
protein	NULL
binding	NULL
to	NULL
a	NULL
consensus	NULL
E	NULL
box	NULL
oligonucleotide	NULL
sequence	NULL
in	NULL
a	NULL
model	NULL
in	NULL
vitro	NULL
band	NULL
shift	NULL
system	NULL
(	NULL
12	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
used	NULL
the	NULL
same	NULL
assay	NULL
system	NULL
to	NULL
evaluate	NULL
the	NULL
func-	NULL
CELL	NULL
CYCLE	NULL
PHOSPHORYLATION	NULL
OF	NULL
Id3	NULL
-	NULL
6817	NULL
tional	NULL
consequences	NULL
of	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
.	NULL

The	NULL
Id1	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
not	NULL
detectably	NULL
phosphorylated	NULL
by	NULL
cyclin	NULL
A-	NULL
or	NULL
E-Cdk2	NULL
,	NULL
provided	NULL
a	NULL
convenient	NULL
control	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
specific	NULL
complexes	NULL
representing	NULL
either	NULL
an	NULL
E12	NULL
homodimer	NULL
or	NULL
an	NULL
E12-MyoD	NULL
heterodimer	NULL
were	NULL
formed	NULL
following	NULL
incubation	NULL
of	NULL
in	NULL
vitro-translated	NULL
protein	NULL
with	NULL
a	NULL
labelled	NULL
E	NULL
box	NULL
oligonucleotide	NULL
.	NULL

Increasing	NULL
the	NULL
inputs	NULL
of	NULL
each	NULL
of	NULL
the	NULL
three	NULL
Id	NULL
proteins	NULL
(	NULL
in	NULL
the	NULL
unphosphorylated	NULL
state	NULL
)	NULL
gave	NULL
qualitatively	NULL
and	NULL
quantitatively	NULL
distinct	NULL
profiles	NULL
of	NULL
inhibition	NULL
of	NULL
homodimer	NULL
and	NULL
heterodimer	NULL
binding	NULL
to	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
Id1	NULL
with	NULL
cyclin-Cdk2	NULL
did	NULL
not	NULL
affect	NULL
this	NULL
inhibition	NULL
,	NULL
whereas	NULL
in	NULL
vitro	NULL
phosphorylation	NULL
of	NULL
Id2	NULL
completely	NULL
neutralized	NULL
its	NULL
function	NULL
,	NULL
as	NULL
expected	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
cyclin	NULL
A-Cdk2	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
altered	NULL
its	NULL
bHLH-antagonizing	NULL
proper-ties	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
Id3	NULL
protein	NULL
in	NULL
its	NULL
unphosphorylated	NULL
state	NULL
,	NULL
which	NULL
inhibits	NULL
E12	NULL
homodimer	NULL
but	NULL
not	NULL
E12-MyoD	NULL
heterodimer	NULL
binding	NULL
,	NULL
the	NULL
in	NULL
vitro-phosphorylated	NULL
Id3	NULL
protein	NULL
inhibits	NULL
exclusively	NULL
the	NULL
E12-MyoD	NULL
heterodimer	NULL
but	NULL
not	NULL
the	NULL
E12	NULL
homodimer	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
E12	NULL
homodimer	NULL
complex	NULL
was	NULL
actually	NULL
increased	NULL
following	NULL
addition	NULL
of	NULL
phosphorylated	NULL
Id3	NULL
protein	NULL
,	NULL
presumably	NULL
as	NULL
a	NULL
result	NULL
of	NULL
sequestration	NULL
of	NULL
the	NULL
MyoD	NULL
partner	NULL
by	NULL
phosphorylated	NULL
Id3	NULL
.	NULL

Since	NULL
MyoD	NULL
does	NULL
not	NULL
form	NULL
an	NULL
E-box-binding	NULL
homodimer	NULL
(	NULL
reference	NULL
22	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
we	NULL
could	NULL
not	NULL
directly	NULL
test	NULL
this	NULL
in	NULL
band	NULL
shift	NULL
assays	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
Ala5	NULL
Id3	NULL
mutant	NULL
behaved	NULL
in	NULL
a	NULL
way	NULL
similar	NULL
to	NULL
the	NULL
wild-type	NULL
protein	NULL
.	NULL

However	NULL
,	NULL
substitution	NULL
of	NULL
a	NULL
highly	NULL
charged	NULL
aspartate	NULL
residue	NULL
at	NULL
position	NULL
5	NULL
(	NULL
Id3	NULL
Asp5	NULL
)	NULL
faithfully	NULL
mimicked	NULL
the	NULL
properties	NULL
of	NULL
the	NULL
in	NULL
vitro-phosphorylated	NULL
Time	NULL
(	NULL
hrs	NULL
)	NULL
-	NULL
O0	NULL
4	NULL
8	NULL
16	NULL
24	NULL
mage	NULL
_-	NULL
e	NULL
%	NULL
,	NULL
%	NULL
g	NULL
Id3-	NULL
»	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

In	NULL
vivo	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
by	NULL
cyclin	NULL
A-	NULL
and	NULL
E-Cdk2	NULL
complexes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Primary	NULL
human	NULL
B	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
and	NULL
then	NULL
radiolabelled	NULL
with	NULL
either	NULL
or	NULL
Id3	NULL
protein	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
cell	NULL
lysates	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
.	NULL

(	NULL
B	NULL
)	NULL
COS	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
either	NULL
wild-type	NULL
(	NULL
Wt	NULL
)	NULL
or	NULL
mutant	NULL
Id3	NULL
protein	NULL
(	NULL
Ser5-Ala5	NULL
)	NULL
and	NULL
then	NULL
radiolabelled	NULL
with	NULL
either	NULL
[	NULL
*S	NULL
)	NULL
methionine	NULL
or	NULL
[	NULL
**PJorthophosphate	NULL
prior	NULL
to	NULL
analysis	NULL
by	NULL
immunoprecipitation	NULL
as	NULL
described	NULL
above	NULL
.	NULL

(	NULL
C	NULL
)	NULL
COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
wild-type	NULL
or	NULL
Ala5	NULL
mutant	NULL
Id3	NULL
expression	NULL
constructs	NULL
in	NULL
combination	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
cyclins	NULL
,	NULL
Cdk2	NULL
,	NULL
and	NULL
Cdk2	NULL
inhibitors	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
labelled	NULL
with	NULL
[	NULL
°PJorthophosphate	NULL
and	NULL
then	NULL
lysed	NULL
and	NULL
analyzed	NULL
by	NULL
immunoprecipitation	NULL
and	NULL
SDS-PAGE	NULL
.	NULL

6818	NULL
DEED	NULL
ET	NULL
AL	NULL
.	NULL

a	NULL
0	NULL
3	NULL
Id1	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

B	NULL
C	NULL
Id2	NULL
[	NULL
eK	NULL
]	NULL
II	NULL
-	NULL
II	NULL
1	NULL
1	NULL
5	NULL
25	NULL
1	NULL
5	NULL
25	NULL
1	NULL
5	NULL
25	NULL
Q0v	NULL
Q0	NULL
»	NULL
QOv	NULL
E12/MyoD-f	NULL
E12/E12	NULL
prove	NULL
-.|	NULL
viii	NULL
d	NULL
U-	NULL
08	NULL
BOH	NULL
Wg	NULL
(	NULL
n-	NULL
amana	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Attenuation	NULL
of	NULL
Id	NULL
function	NULL
by	NULL
phosphorylation	NULL
at	NULL
Ser5	NULL
.	NULL

Band	NULL
shift	NULL
analyses	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
*°P-labelled	NULL
E	NULL
box	NULL
oligonucleotide	NULL
probe	NULL
together	NULL
with	NULL
in	NULL
vitro-translated	NULL
E12	NULL
and	NULL
MyoD	NULL
proteins	NULL
.	NULL

The	NULL
retarded	NULL
complexes	NULL
corresponding	NULL
to	NULL
the	NULL
E12	NULL
homodimer	NULL
(	NULL
con	NULL
.	NULL

E12	NULL
)	NULL
and	NULL
to	NULL
the	NULL
E12-MyoD	NULL
heterodimer	NULL
(	NULL
con	NULL
.	NULL

E12/MyoD	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
;	NULL
the	NULL
specificity	NULL
of	NULL
interaction	NULL
was	NULL
confirmed	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabelled	NULL
wild-type	NULL
(	NULL
Wt	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
Mut	NULL
)	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Complexes	NULL
were	NULL
challenged	NULL
with	NULL
increasing	NULL
inputs	NULL
of	NULL
each	NULL
histidine-tagged	NULL
Id	NULL
protein	NULL
(	NULL
B	NULL
)	NULL
or	NULL
with	NULL
25	NULL
ng	NULL
of	NULL
each	NULL
Id	NULL
protein	NULL
either	NULL
unphosphorylated	NULL
or	NULL
in	NULL
vitro-phosphorylated	NULL
with	NULL
a	NULL
cell	NULL
extract	NULL
from	NULL
Sf9	NULL
cells	NULL
expressing	NULL
baculovirus-encoded	NULL
cyclin	NULL
A-Cdk2	NULL
(	NULL
C	NULL
)	NULL
.	NULL

1Id3	NULL
protein	NULL
.	NULL

A	NULL
control	NULL
Id3	NULL
mutant	NULL
which	NULL
incorporates	NULL
a	NULL
helix-breaking	NULL
proline	NULL
residue	NULL
(	NULL
Pro49	NULL
)	NULL
in	NULL
the	NULL
H1	NULL
domain	NULL
(	NULL
8	NULL
)	NULL
was	NULL
almost	NULL
totally	NULL
ineffectual	NULL
in	NULL
inhibiting	NULL
either	NULL
homodimer	NULL
or	NULL
heterodimer	NULL
bHLH	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
were	NULL
confirmed	NULL
in	NULL
band	NULL
shift	NULL
assays	NULL
evaluating	NULL
E12	NULL
homodimer	NULL
binding	NULL
in	NULL
isolation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
phosphorylation	NULL
on	NULL
in	NULL
vivo	NULL
gene	NULL
expression	NULL
and	NULL
biological	NULL
properties	NULL
of	NULL
Id3	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
in	NULL
vivo	NULL
consequences	NULL
of	NULL
Id3	NULL
phosphorylation	NULL
at	NULL
serine	NULL
5	NULL
,	NULL
we	NULL
used	NULL
constructs	NULL
expressing	NULL
wild-type	NULL
Id3	NULL
or	NULL
the	NULL
phosphorylation-mimicking	NULL
mutant	NULL
(	NULL
AspS	NULL
)	NULL
to	NULL
challenge	NULL
E12-MyoD	NULL
transactivation	NULL
of	NULL
an	NULL
E-box-dependent	NULL
reporter	NULL
gene	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
increasing	NULL
inputs	NULL
of	NULL
wild-type	NULL
Id3	NULL
significantly	NULL
inhibited	NULL
transactivation	NULL
of	NULL
the	NULL
E-box-dependent	NULL
reporter	NULL
.	NULL

This	NULL
contrasts	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
inhibition	NULL
of	NULL
heterodimer	NULL
complex	NULL
seen	NULL
in	NULL
band	NULL
shift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
can	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
exogenous	NULL
1d3	NULL
protein	NULL
becoming	NULL
partially	NULL
phosphorylated	NULL
in	NULL
transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
band	NULL
shift	NULL
data	NULL
above	NULL
,	NULL
the	NULL
Id3	NULL
Asp	NULL
mutant	NULL
was	NULL
much	NULL
more	NULL
potent	NULL
than	NULL
wild-type	NULL
Id3	NULL
,	NULL
whereas	NULL
the	NULL
Pro49	NULL
(	NULL
helix-breaking	NULL
)	NULL
mutant	NULL
had	NULL
only	NULL
a	NULL
marginal	NULL
effect	NULL
on	NULL
reporter	NULL
gene	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

To	NULL
further	NULL
establish	NULL
that	NULL
this	NULL
enhanced	NULL
activity	NULL
of	NULL
the	NULL
1d3	NULL
Asp	NULL
mutant	NULL
in	NULL
inhibiting	NULL
E-box-dependent	NULL
reporter	NULL
function	NULL
is	NULL
due	NULL
to	NULL
increased	NULL
potency	NULL
in	NULL
inhibition	NULL
of	NULL
E12-MyoD	NULL
interaction	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
competitive	NULL
Gal4-Vp16	NULL
two-hybrid	NULL
assay	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

In	NULL
response	NULL
to	NULL
increasing	NULL
inputs	NULL
of	NULL
the	NULL
wild-type	NULL
Id3	NULL
expression	NULL
vector	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
Gal4E12-Vp16MyoD	NULL
interaction	NULL
was	NULL
significantly	NULL
inhibited	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
wild-type	NULL
protein	NULL
to	NULL
inhibit	NULL
E-box-dependent	NULL
reporter	NULL
gene	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
Pro49	NULL
helix-breaking	NULL
Id3	NULL
mutant	NULL
displayed	NULL
no	NULL
significant	NULL
inhibitory	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
the	NULL
Id3	NULL
Asp5	NULL
mutant	NULL
was	NULL
again	NULL
more	NULL
potent	NULL
than	NULL
wild-type	NULL
Id3	NULL
at	NULL
disrupting	NULL
E12-MyoD	NULL
heterodimer	NULL
formation	NULL
in	NULL
vivo	NULL
.	NULL

Enforced	NULL
ectopic	NULL
expression	NULL
of	NULL
Id3	NULL
under	NULL
appropriate	NULL
con	NULL
ditions	NULL
promotes	NULL
cell	NULL
growth	NULL
and	NULL
allows	NULL
cells	NULL
to	NULL
continue	NULL
cycling	NULL
under	NULL
conditions	NULL
of	NULL
low	NULL
serum	NULL
(	NULL
1	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
used	NULL
this	NULL
as	NULL
an	NULL
end	NULL
point	NULL
to	NULL
evaluate	NULL
the	NULL
possible	NULL
biological	NULL
significance	NULL
of	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
at	NULL
serine	NULL
5	NULL
.	NULL

Expression	NULL
constructs	NULL
encoding	NULL
wild-type	NULL
Id3	NULL
and	NULL
phosphorylation-mimicking	NULL
and	NULL
phosphorylation-ablating	NULL
mutants	NULL
of	NULL
Id3	NULL
were	NULL
transfected	NULL
into	NULL
rat	NULL
embryo	NULL
fibroblasts	NULL
along	NULL
with	NULL
a	NULL
LacZ	NULL
marker	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
placed	NULL
in	NULL
low	NULL
serum	NULL
and	NULL
subsequently	NULL
pulsed	NULL
with	NULL
g	NULL
4	NULL
Id3Wwt	NULL
IIId3Ak	NULL
'	NULL
.	NULL

!	NULL

5I	NULL
IIdSAsE	NULL
‘	NULL
IId3Pr049I	NULL
0	NULL
&	NULL
61520152015201520	NULL
é	NULL
?	NULL

$	NULL
n	NULL
NQJ	NULL
“	NULL
SJ	NULL
“	NULL
QJ	NULL
bos	NULL
|	NULL
tour	NULL
.	NULL

Nai	NULL
Win	NULL
Gaw	NULL
)	NULL
WW	NULL
#	NULL
©	NULL
<	NULL
was	NULL
wee	NULL
E12/MyoD	NULL
EI¥	NULL
%	NULL
E12	NULL
DODC	NULL
--	NULL
+	NULL
)	NULL
pups	NULL
Orme	NULL
.	NULL

FIG	NULL
.	NULL

4	NULL
.	NULL

Effects	NULL
of	NULL
phosphorylation-mimicking	NULL
and	NULL
phosphorylation-ablating	NULL
Id3	NULL
mutants	NULL
on	NULL
E12-MyoD	NULL
heterodimer	NULL
bHLH-E	NULL
box	NULL
binding	NULL
.	NULL

Band	NULL
shift	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
and	NULL
complexes	NULL
were	NULL
challenged	NULL
with	NULL
increasing	NULL
inputs	NULL
of	NULL
bacterially	NULL
synthesized	NULL
wild-type	NULL
(	NULL
Wt	NULL
)	NULL
Id3	NULL
or	NULL
the	NULL
Ala5	NULL
,	NULL
Asp5	NULL
,	NULL
or	NULL
Pro49	NULL
mutant	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
Id1	NULL
Id2	NULL
Id3Wt_	NULL
Jd3Ala5_	NULL
1d3Asp5	NULL
Id3Pr049	NULL
COF	NULL
IT	NULL
1	NULL
I	NULL
|	NULL
1	NULL
T	NULL
|	NULL
p	NULL
20	NULL
20	NULL
1	NULL
5	NULL
20	NULL
1	NULL
5	NULL
20	NULL
1	NULL
5	NULL
20	NULL
1	NULL
5	NULL
20	NULL
8	NULL
ng	NULL
ng	NULL
ng	NULL
ng	NULL
|_	NULL
E12/E12	NULL
g	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
phosphorylation-mimicking	NULL
and	NULL
phosphorylation-ablating	NULL
Id3	NULL
mutants	NULL
on	NULL
E12	NULL
homodimeric	NULL
bHLH-E	NULL
box	NULL
binding	NULL
.	NULL

Band	NULL
shift	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
and	NULL
complexes	NULL
were	NULL
challenged	NULL
with	NULL
increasing	NULL
inputs	NULL
of	NULL
bacterially	NULL
synthesized	NULL
wild-type	NULL
(	NULL
Wt	NULL
)	NULL
Id3	NULL
or	NULL
the	NULL
Ala5	NULL
,	NULL
Asp5	NULL
,	NULL
or	NULL
Pro49	NULL
mutant	NULL
.	NULL

BrdU	NULL
to	NULL
determine	NULL
the	NULL
proportion	NULL
of	NULL
cells	NULL
that	NULL
remained	NULL
in	NULL
cycle	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
approximately	NULL
15	NULL
%	NULL
of	NULL
the	NULL
Id3-transfected	NULL
cells	NULL
incorporated	NULL
BrdU	NULL
,	NULL
compared	NULL
to	NULL
only	NULL
3	NULL
%	NULL
of	NULL
the	NULL
vector-only	NULL
transfected	NULL
controls	NULL
.	NULL

The	NULL
proportion	NULL
of	NULL
cycling	NULL
cells	NULL
was	NULL
even	NULL
higher	NULL
with	NULL
the	NULL
nonphosphorylatable	NULL
Ala5	NULL
mutant	NULL
(	NULL
23	NULL
%	NULL
)	NULL
,	NULL
although	NULL
this	NULL
effect	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
degree	NULL
of	NULL
cytotoxicity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
AspS5	NULL
and	NULL
Pro49	NULL
mutants	NULL
of	NULL
Id3	NULL
had	NULL
only	NULL
a	NULL
marginal	NULL
effect	NULL
on	NULL
the	NULL
proportion	NULL
of	NULL
cycling	NULL
cells	NULL
relative	NULL
to	NULL
the	NULL
control	NULL
.	NULL

DISCUSSION	NULL
Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
during	NULL
the	NULL
transition	NULL
from	NULL
G	NULL
,	NULL
,	NULL
to	NULL
S	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
bHLH	NULL
proteins	NULL
,	NULL
exemplified	NULL
by	NULL
E2A-related	NULL
E	NULL
proteins	NULL
,	NULL
remain	NULL
essentially	NULL
constant	NULL
(	NULL
12	NULL
,	NULL
25	NULL
)	NULL
.	NULL

However	NULL
,	NULL
during	NULL
early	NULL
G	NULL
,	NULL
the	NULL
activities	NULL
of	NULL
bHLH	NULL
proteins	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
cellular	NULL
protein	NULL
extract	NULL
to	NULL
E	NULL
box	NULL
oligonucleotides	NULL
in	NULL
vitro	NULL
,	NULL
are	NULL
transiently	NULL
depressed	NULL
at	NULL
a	NULL
time	NULL
coincident	NULL
with	NULL
the	NULL
peak	NULL
of	NULL
induction	NULL
of	NULL
Id	NULL
proteins	NULL
(	NULL
12	NULL
,	NULL
25	NULL
)	NULL
.	NULL

In	NULL
exponentially	NULL
growing	NULL
cells	NULL
,	NULL
most	NULL
of	NULL
the	NULL
cellular	NULL
E2A-related	NULL
protein	NULL
is	NULL
associated	NULL
with	NULL
Id	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
in	NULL
most	NULL
cell	NULL
types	NULL
different	NULL
Id	NULL
proteins	NULL
are	NULL
typically	NULL
coexpressed	NULL
(	NULL
4	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Since	NULL
Id	NULL
proteins	NULL
display	NULL
both	NULL
qualitative	NULL
and	NULL
quantitative	NULL
differences	NULL
in	NULL
target	NULL
bHLH	NULL
protein	NULL
specificity	NULL
(	NULL
reference	NULL
12	NULL
and	NULL
as	NULL
reported	NULL
herein	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
they	NULL
act	NULL
cooperatively	NULL
to	NULL
transiently	NULL
abrogate	NULL
the	NULL
function	NULL
of	NULL
multiple	NULL
(	NULL
as	NULL
yet	NULL
uncharacterized	NULL
)	NULL
bHLH	NULL
proteins	NULL
as	NULL
an	NULL
essential	NULL
mechanism	NULL
of	NULL
early	NULL
G	NULL
,	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

However	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Id	NULL
proteins	NULL
persists	NULL
into	NULL
late	NULL
G	NULL
,	NULL
and	NULL
throughout	NULL
S	NULL
phase	NULL
,	NULL
and	NULL
indeed	NULL
a	NULL
second	NULL
peak	NULL
of	NULL
induction	NULL
is	NULL
seen	NULL
during	NULL
late	NULL
G	NULL
,	NULL
-to-S	NULL
phase	NULL
(	NULL
13	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
functional	NULL
role	NULL
beyond	NULL
early	NULL
G	NULL
,	NULL
.	NULL

Enigmatically	NULL
,	NULL
the	NULL
cyclin	NULL
A-and	NULL
E-Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
Id2	NULL
at	NULL
late	NULL
G	NULL
,	NULL
was	NULL
previously	NULL
found	NULL
to	NULL
completely	NULL
inactivate	NULL
the	NULL
function	NULL
of	NULL
this	NULL
Id	NULL
protein	NULL
in	NULL
antagonizing	NULL
homodimer	NULL
and	NULL
heterodimer	NULL
binding	NULL
to	NULL
an	NULL
E	NULL
box	NULL
oligonucleotide	NULL
in	NULL
vitro	NULL
(	NULL
12	NULL
)	NULL
.	NULL

While	NULL
this	NULL
loss	NULL
of	NULL
1Id2	NULL
activity	NULL
might	NULL
well	NULL
explain	NULL
the	NULL
restoration	NULL
of	NULL
bHLH	NULL
E	NULL
box	NULL
binding	NULL
activity	NULL
seen	NULL
in	NULL
cellular	NULL
extracts	NULL
at	NULL
late	NULL
G	NULL
;	NULL
,	NULL
in	NULL
these	NULL
experiments	NULL
,	NULL
it	NULL
also	NULL
cast	NULL
some	NULL
doubt	NULL
on	NULL
the	NULL
functional	NULL
relevance	NULL
of	NULL
this	NULL
phosphorylated	NULL
Id2	NULL
protein	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
for	NULL
CELL	NULL
CYCLE	NULL
PHOSPHORYLATION	NULL
OF	NULL
Id3	NULL
-	NULL
6819	NULL
tuitous	NULL
differences	NULL
in	NULL
bHLH-antagonizing	NULL
properties	NULL
between	NULL
Id2	NULL
and	NULL
the	NULL
related	NULL
Id3	NULL
protein	NULL
,	NULL
we	NULL
have	NULL
now	NULL
been	NULL
able	NULL
to	NULL
show	NULL
that	NULL
analogous	NULL
cyclin	NULL
A-	NULL
and	NULL
E-Cdk2-dependent	NULL
cell	NULL
cycle	NULL
phosphorylation	NULL
of	NULL
Id3	NULL
does	NULL
in	NULL
fact	NULL
change	NULL
its	NULL
target	NULL
bHLH	NULL
specificity	NULL
.	NULL

Whereas	NULL
unphosphorylated	NULL
Id3	NULL
abrogates	NULL
an	NULL
E12	NULL
homodimer	NULL
complex	NULL
but	NULL
not	NULL
the	NULL
E12-MyoD	NULL
heterodimer	NULL
,	NULL
phosphorylation	NULL
at	NULL
serine	NULL
5	NULL
or	NULL
substitution	NULL
of	NULL
a	NULL
highly	NULL
charged	NULL
aspartate	NULL
residue	NULL
at	NULL
this	NULL
position	NULL
results	NULL
in	NULL
a	NULL
switch	NULL
to	NULL
abrogation	NULL
of	NULL
the	NULL
E12-MyoD	NULL
heterodimer	NULL
complex	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
Id3	NULL
AspS5	NULL
mutant	NULL
inhibited	NULL
E12-MyoD	NULL
transactivation	NULL
of	NULL
an	NULL
E-box-driven	NULL
reporter	NULL
and	NULL
Gal4E12-Vp16MyoD	NULL
interaction	NULL
in	NULL
vivo	NULL
more	NULL
efficiently	NULL
than	NULL
the	NULL
wild-type	NULL
protein	NULL
,	NULL
although	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
evaluate	NULL
each	NULL
bHLH	NULL
protein	NULL
partner	NULL
in	NULL
isolation	NULL
since	NULL
the	NULL
respective	NULL
homodimers	NULL
gave	NULL
only	NULL
a	NULL
minimal	NULL
transactivation	NULL
of	NULL
the	NULL
reporters	NULL
in	NULL
these	NULL
assays	NULL
(	NULL
reference	NULL
22	NULL
and	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
could	NULL
not	NULL
be	NULL
explained	NULL
purely	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
expression	NULL
levels	NULL
or	NULL
by	NULL
differences	NULL
in	NULL
Id	NULL
protein	NULL
stabilities	NULL
,	NULL
which	NULL
were	NULL
comparable	NULL
in	NULL
control	NULL
transfection	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
phospho-rylation-dependent	NULL
modulation	NULL
of	NULL
Id	NULL
protein	NULL
specificity	NULL
is	NULL
somewhat	NULL
reminiscent	NULL
of	NULL
that	NULL
reported	NULL
for	NULL
phosphorylation	NULL
of	NULL
E2A	NULL
and	NULL
MyoD	NULL
(	NULL
26	NULL
,	NULL
38	NULL
)	NULL
and	NULL
serves	NULL
to	NULL
emphasize	NULL
the	NULL
role	NULL
of	NULL
determinants	NULL
mapping	NULL
outside	NULL
of	NULL
the	NULL
bHLH	NULL
domain	NULL
in	NULL
determining	NULL
the	NULL
dimerization	NULL
specificity	NULL
of	NULL
Id	NULL
proteins	NULL
,	NULL
as	NULL
previously	NULL
implied	NULL
from	NULL
molecular	NULL
modelling	NULL
studies	NULL
(	NULL
43	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
N-terminal	NULL
domains	NULL
of	NULL
both	NULL
the	NULL
Id2	NULL
and	NULL
Id3	NULL
proteins	NULL
contain	NULL
a	NULL
flexible	NULL
hinge	NULL
region	NULL
between	NULL
amino	NULL
acids	NULL
20	NULL
and	NULL
35	NULL
that	NULL
would	NULL
permit	NULL
juxtaposition	NULL
of	NULL
the	NULL
serine	NULL
5	NULL
100	NULL
80	NULL
-	NULL
2	NULL
-	NULL
60	NULL
_	NULL
@	NULL
]	NULL
|_	NULL
S	NULL
l—	NULL
O	NULL
-	NULL
40	NULL
_	NULL
<	NULL
Q	NULL
_	NULL
O	NULL
LL	NULL
20	NULL
-	NULL
_|	NULL
0	NULL
E12/MyoD	NULL
2.5	NULL
25	NULL
2.5	NULL
25	NULL
25	NULL
25	NULL
25	NULL
2.5	NULL
Wtld3	NULL
1.0	NULL
2.5	NULL
5.0	NULL
-	NULL
-	NULL
-	NULL
Id3Asp5	NULL
-	NULL
-	NULL
=o	NULL
=	NULL
1.0	NULL
25	NULL
5.0	NULL
1d3Pro49	NULL
h	NULL
=	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
5.0	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Enhanced	NULL
activity	NULL
of	NULL
the	NULL
Id3	NULL
phosphorylation	NULL
mimic	NULL
on	NULL
E12-MyoD-dependent	NULL
gene	NULL
expression	NULL
in	NULL
vivo	NULL
.	NULL

Fibroblasts	NULL
were	NULL
transfected	NULL
with	NULL
2.5	NULL
ug	NULL
of	NULL
E-box-driven	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
in	NULL
combination	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
E12-MyoD	NULL
,	NULL
wild-type	NULL
(	NULL
Wt	NULL
)	NULL
Id3	NULL
,	NULL
Id3	NULL
Asp5	NULL
,	NULL
or	NULL
Id3	NULL
Pro49	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Transfected	NULL
DNA	NULL
was	NULL
normalized	NULL
to	NULL
a	NULL
total	NULL
of	NULL
15	NULL
ug	NULL
with	NULL
peDNA3	NULL
carrier	NULL
plasmid	NULL
together	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
luciferase	NULL
reporter	NULL
driven	NULL
by	NULL
a	NULL
heterologous	NULL
cytomegalovirus	NULL
promoter	NULL
as	NULL
a	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Twenty-four	NULL
hours	NULL
posttransfection	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
relative	NULL
CAT	NULL
activities	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
[	NULL
'*CJchloramphenicol	NULL
and	NULL
thin-layer	NULL
chromatography	NULL
with	NULL
quantitation	NULL
by	NULL
phosphoimage	NULL
analysis	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
were	NULL
determined	NULL
from	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

6820	NULL
DEED	NULL
ET	NULL
AL	NULL
.	NULL

25	NULL
~	NULL
10	NULL
FOLD	NULL
ACTIVATION	NULL
0	NULL
_	NULL
_I	NULL
E12/MyoD	NULL
-	NULL
2.0	NULL
2.0	NULL
20	NULL
2.0	NULL
2.0	NULL
2.0	NULL
2.0	NULL
2.0	NULL
Wilds	NULL
-o	NULL
>	NULL
1.0	NULL
25	NULL
5.000	NULL
}	NULL
0	NULL
-	NULL
-	NULL
o	NULL
>	NULL
Id3Asp5	NULL
-	NULL
-	NULL
-o-	NULL
-	NULL
1.0	NULL
25	NULL
5.0	NULL
1d3Pro49	NULL
mom	NULL
mm	NULL
mr	NULL
nn	NULL
5.0	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Enhanced	NULL
inhibition	NULL
of	NULL
Gal4E12-Vp16MyoD	NULL
interaction	NULL
in	NULL
vivo	NULL
by	NULL
the	NULL
Id3	NULL
phosphorylation-mimicking	NULL
Asp5	NULL
mutant	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
cach	NULL
of	NULL
the	NULL
Gal4	NULL
luciferase	NULL
reporter	NULL
pGSElbLuc	NULL
,	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
-driven	NULL
Renilla	NULL
luciferase	NULL
expression	NULL
vector	NULL
pRLCMV	NULL
,	NULL
and	NULL
the	NULL
pGal4E12	NULL
and	NULL
pVp16MyoD	NULL
fusion	NULL
vectors	NULL
,	NULL
together	NULL
with	NULL
each	NULL
of	NULL
the	NULL
CMV-driven	NULL
expression	NULL
constructs	NULL
indicated	NULL
plus	NULL
pcDNA3	NULL
empty	NULL
vector	NULL
to	NULL
normalize	NULL
for	NULL
DNA	NULL
input	NULL
.	NULL

At	NULL
24	NULL
h	NULL
posttransfection	NULL
,	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Wt	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

phosphorylatable	NULL
residue	NULL
with	NULL
the	NULL
respective	NULL
HLH	NULL
regions	NULL
of	NULL
these	NULL
Id	NULL
proteins	NULL
.	NULL

Although	NULL
these	NULL
studies	NULL
utilizing	NULL
model	NULL
bHLH	NULL
proteins	NULL
dramatically	NULL
illustrate	NULL
the	NULL
consequences	NULL
of	NULL
cyclin	NULL
A-	NULL
and	NULL
E-Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
Id	NULL
proteins	NULL
on	NULL
their	NULL
functional	NULL
properties	NULL
,	NULL
we	NULL
have	NULL
no	NULL
information	NULL
on	NULL
how	NULL
this	NULL
relates	NULL
to	NULL
their	NULL
in	NULL
vivo	NULL
cellular	NULL
bHLH	NULL
target	NULL
proteins	NULL
during	NULL
late	NULL
G	NULL
,	NULL
and	NULL
S	NULL
phase	NULL
.	NULL

This	NULL
clearly	NULL
represents	NULL
an	NULL
important	NULL
area	NULL
for	NULL
future	NULL
investigation	NULL
.	NULL

Given	NULL
the	NULL
rapidly	NULL
expanding	NULL
number	NULL
of	NULL
reported	NULL
bHLH	NULL
transcription	NULL
factors	NULL
(	NULL
24	NULL
)	NULL
,	NULL
it	NULL
is	NULL
highly	NULL
probable	NULL
that	NULL
phosphorylation	NULL
of	NULL
Id2	NULL
,	NULL
as	NULL
with	NULL
1d3	NULL
,	NULL
results	NULL
in	NULL
acquisition	NULL
of	NULL
altered	NULL
target	NULL
bHLH	NULL
specificity	NULL
rather	NULL
than	NULL
complete	NULL
loss	NULL
of	NULL
bHLH	NULL
functional	NULL
antagonism	NULL
,	NULL
as	NULL
previously	NULL
observed	NULL
in	NULL
in	NULL
vitro	NULL
bandshift	NULL
assays	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Since	NULL
substitution	NULL
of	NULL
a	NULL
phosphorylation-mimicking	NULL
Asp	NULL
residue	NULL
at	NULL
SerS	NULL
in	NULL
Id3	NULL
faithfully	NULL
reproduced	NULL
the	NULL
properties	NULL
of	NULL
the	NULL
phosphorylated	NULL
Id3	NULL
protein	NULL
seen	NULL
in	NULL
in	NULL
vitro	NULL
band	NULL
shift	NULL
assays	NULL
and	NULL
imparted	NULL
a	NULL
similar	NULL
shift	NULL
towards	NULL
functional	NULL
antagonism	NULL
of	NULL
bHLH	NULL
heterodimer-dependent	NULL
gene	NULL
expression	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
use	NULL
this	NULL
mutant	NULL
to	NULL
address	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
Cdk2-dependent	NULL
phosphorylation	NULL
at	NULL
a	NULL
biological	NULL
level	NULL
.	NULL

In	NULL
several	NULL
reported	NULL
studies	NULL
,	NULL
enforced	NULL
ectopic	NULL
expression	NULL
of	NULL
Id	NULL
genes	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
promote	NULL
cell	NULL
growth	NULL
and	NULL
to	NULL
delay	NULL
exit	NULL
from	NULL
the	NULL
cell	NULL
cycle	NULL
on	NULL
removal	NULL
of	NULL
mitogens	NULL
;	NULL
this	NULL
represents	NULL
an	NULL
important	NULL
mechanism	NULL
through	NULL
which	NULL
Id	NULL
proteins	NULL
arrest	NULL
cell	NULL
differentiation	NULL
(	NULL
1	NULL
,	NULL
10	NULL
,	NULL
15	NULL
)	NULL
.	NULL

The	NULL
AspS	NULL
Id3	NULL
mutant	NULL
was	NULL
completely	NULL
devoid	NULL
of	NULL
any	NULL
activity	NULL
in	NULL
promoting	NULL
S	NULL
phase	NULL
,	NULL
implying	NULL
that	NULL
Cdk-dependent	NULL
phosphorylation	NULL
inactivates	NULL
the	NULL
G	NULL
,	NULL
-to-S	NULL
cell	NULL
cycle	NULL
regulatory	NULL
function	NULL
of	NULL
this	NULL
Id	NULL
protein	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
AlaS	NULL
Id3	NULL
variant	NULL
imparted	NULL
a	NULL
``	NULL
gain-of-function	NULL
``	NULL
phenotype	NULL
associated	NULL
with	NULL
extensive	NULL
cell	NULL
death	NULL
(	NULL
a	NULL
property	NULL
which	NULL
also	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

precluded	NULL
analysis	NULL
of	NULL
reporter	NULL
gene	NULL
function	NULL
with	NULL
this	NULL
mutant	NULL
)	NULL
.	NULL

In	NULL
further	NULL
experiments	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
a	NULL
similar	NULL
though	NULL
less	NULL
dramatic	NULL
effect	NULL
with	NULL
an	NULL
Id2	NULL
Alas	NULL
mutant	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
the	NULL
Id2	NULL
Ala5	NULL
mutant	NULL
was	NULL
found	NULL
to	NULL
display	NULL
cell	NULL
toxicity	NULL
,	NULL
since	NULL
it	NULL
significantly	NULL
reduced	NULL
colony-forming	NULL
efficiency	NULL
in	NULL
stable	NULL
transfectants	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
exact	NULL
nature	NULL
of	NULL
the	NULL
acute	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
Id3	NULL
(	NULL
and	NULL
Id2	NULL
)	NULL
AlaS	NULL
mutants	NULL
revealed	NULL
in	NULL
the	NULL
present	NULL
study	NULL
is	NULL
intriguing	NULL
,	NULL
although	NULL
it	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
involve	NULL
induction	NULL
of	NULL
a	NULL
classical	NULL
apoptotic	NULL
phenotype	NULL
and	NULL
more	NULL
likely	NULL
is	NULL
the	NULL
result	NULL
of	NULL
an	NULL
alternative	NULL
``	NULL
cell	NULL
suicide	NULL
``	NULL
mechanism	NULL
(	NULL
11	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
most	NULL
of	NULL
the	NULL
Id3	NULL
AlaS-transfected	NULL
cells	NULL
displaying	NULL
features	NULL
of	NULL
cell	NULL
death	NULL
were	NULL
also	NULL
in	NULL
S	NULL
phase	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
increased	NULL
percentage	NULL
of	NULL
transfected	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
seen	NULL
with	NULL
this	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
is	NULL
therefore	NULL
not	NULL
simply	NULL
attributable	NULL
to	NULL
selective	NULL
killing	NULL
of	NULL
cells	NULL
that	NULL
are	NULL
not	NULL
entering	NULL
S	NULL
phase	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
death	NULL
of	NULL
Id3	NULL
AlaS-transfected	NULL
cells	NULL
may	NULL
have	NULL
led	NULL
to	NULL
an	NULL
underestimation	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
mutant	NULL
to	NULL
promote	NULL
S	NULL
phase	NULL
.	NULL

With	NULL
the	NULL
caveat	NULL
that	NULL
these	NULL
transfection	NULL
experiments	NULL
generate	NULL
nonphysiological	NULL
levels	NULL
of	NULL
Id	NULL
proteins	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
Id2	NULL
and	NULL
Id3	NULL
proteins	NULL
during	NULL
late	NULL
G	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
progression	NULL
through	NULL
,	NULL
or	NULL
exit	NULL
from	NULL
,	NULL
S	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

While	NULL
the	NULL
phosphorylated	NULL
Id	NULL
proteins	NULL
are	NULL
nonfunctional	NULL
in	NULL
promoting	NULL
cell	NULL
growth	NULL
,	NULL
they	NULL
nonetheless	NULL
antagonize	NULL
E-box-dependent	NULL
gene	NULL
expression	NULL
,	NULL
albeit	NULL
with	NULL
altered	NULL
specificity	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
unphosphorylated	NULL
Id	NULL
protein	NULL
may	NULL
target	NULL
a	NULL
set	NULL
of	NULL
bHLH	NULL
proteins	NULL
(	NULL
and	NULL
possibly	NULL
other	NULL
proteins	NULL
)	NULL
important	NULL
for	NULL
regulating	NULL
G1	NULL
progression	NULL
,	NULL
their	NULL
phosphorylated	NULL
counterparts	NULL
may	NULL
antagonize	NULL
a	NULL
distinct	NULL
set	NULL
of	NULL
bHLH	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
perhaps	NULL
more	NULL
important	NULL
in	NULL
regulating	NULL
differentiation-linked	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
data	NULL
illustrate	NULL
that	NULL
the	NULL
cell	NULL
cycle	NULL
regulatory	NULL
functions	NULL
of	NULL
Id	NULL
proteins	NULL
in	NULL
promoting	NULL
S	NULL
phase	NULL
entry	NULL
(	NULL
at	NULL
least	NULL
as	NULL
illustrated	NULL
for	NULL
Id3	NULL
)	NULL
may	NULL
be	NULL
dissociated	NULL
from	NULL
the	NULL
ability	NULL
to	NULL
modulate	NULL
bHLH	NULL
heterodimer-dependent	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
further	NULL
underscores	NULL
the	NULL
analogy	NULL
between	NULL
Ids	NULL
and	NULL
their	NULL
opposing	NULL
bHLH	NULL
partners	NULL
,	NULL
in	NULL
which	NULL
these	NULL
functional	NULL
30	NULL
20	NULL
10	NULL
«	NULL
-I	NULL
%	NULL
CELLS	NULL
IN	NULL
S	NULL
PHASE	NULL
~-	NULL
Con	NULL
Id3	NULL
1d3	NULL
Id3	NULL
1d3	NULL
WT	NULL
Ala5	NULL
AspS5	NULL
Pro49	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Id3	NULL
mutants	NULL
selectively	NULL
promote	NULL
cell	NULL
cycle	NULL
S	NULL
phase	NULL
in	NULL
serum-starved	NULL
fibroblasts	NULL
.	NULL

Rat	NULL
embryo	NULL
fibroblasts	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
the	NULL
indicated	NULL
Id3	NULL
expression	NULL
constructs	NULL
(	NULL
wild	NULL
type	NULL
[	NULL
WT	NULL
]	NULL
or	NULL
mutant	NULL
)	NULL
in	NULL
combination	NULL
with	NULL
an	NULL
expression	NULL
construct	NULL
encoding	NULL
a	NULL
lacZ	NULL
marker	NULL
gene	NULL
.	NULL

Control	NULL
cells	NULL
(	NULL
Con	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
lacZ	NULL
marker	NULL
gene	NULL
alone	NULL
.	NULL

Twenty-four	NULL
hours	NULL
posttransfection	NULL
,	NULL
cells	NULL
were	NULL
serum	NULL
starved	NULL
(	NULL
0.1	NULL
%	NULL
FCS	NULL
)	NULL
and	NULL
,	NULL
after	NULL
a	NULL
further	NULL
24	NULL
h	NULL
,	NULL
were	NULL
pulse	NULL
labelled	NULL
with	NULL
BrdU	NULL
.	NULL

Cells	NULL
were	NULL
fixed	NULL
,	NULL
and	NULL
lecZ-positive	NULL
cells	NULL
were	NULL
scored	NULL
by	NULL
immunofluorescence	NULL
in	NULL
combination	NULL
with	NULL
detection	NULL
of	NULL
BrdU	NULL
by	NULL
use	NULL
of	NULL
a	NULL
commercial	NULL
immunofluorescence	NULL
detection	NULL
kit	NULL
(	NULL
Boehringer	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
lecZ-positive	NULL
cells	NULL
appearing	NULL
in	NULL
S	NULL
phase	NULL
and	NULL
are	NULL
taken	NULL
from	NULL
two	NULL
experiments	NULL
in	NULL
which	NULL
a	NULL
minimum	NULL
of	NULL
200	NULL
ZecZ-positive	NULL
cells	NULL
were	NULL
evaluated	NULL
for	NULL
each	NULL
transfection	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
attributes	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
dissociable	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Mutants	NULL
of	NULL
bHLH	NULL
proteins	NULL
that	NULL
are	NULL
attenuated	NULL
in	NULL
the	NULL
capacity	NULL
to	NULL
activate	NULL
differentiation-linked	NULL
gene	NULL
expression	NULL
are	NULL
still	NULL
functional	NULL
in	NULL
promoting	NULL
cell	NULL
cycle	NULL
arrest	NULL
(	NULL
7	NULL
,	NULL
40	NULL
)	NULL
.	NULL

The	NULL
G	NULL
,	NULL
-to-S	NULL
phase	NULL
transition	NULL
in	NULL
mammalian	NULL
cells	NULL
is	NULL
regulated	NULL
through	NULL
the	NULL
sequential	NULL
and	NULL
concerted	NULL
actions	NULL
of	NULL
Cdk	NULL
's	NULL
and	NULL
their	NULL
regulatory	NULL
partners	NULL
,	NULL
which	NULL
culminate	NULL
in	NULL
phosphorylation	NULL
of	NULL
pRB	NULL
and	NULL
related	NULL
pocket	NULL
proteins	NULL
,	NULL
thereby	NULL
alleviating	NULL
inhibition	NULL
of	NULL
E2F	NULL
and	NULL
DP	NULL
family	NULL
transcription	NULL
factors	NULL
,	NULL
whose	NULL
activities	NULL
are	NULL
required	NULL
for	NULL
further	NULL
progression	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
5	NULL
,	NULL
16	NULL
,	NULL
19	NULL
,	NULL
21	NULL
,	NULL
27	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
number	NULL
of	NULL
other	NULL
signalling	NULL
molecules	NULL
,	NULL
typically	NULL
encoded	NULL
by	NULL
early	NULL
response	NULL
genes	NULL
such	NULL
as	NULL
the	NULL
Id	NULL
proteins	NULL
,	NULL
are	NULL
also	NULL
required	NULL
for	NULL
G	NULL
,	NULL
-to-S	NULL
phase	NULL
cell	NULL
cycle	NULL
progression	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Understanding	NULL
how	NULL
the	NULL
functions	NULL
of	NULL
these	NULL
seemingly	NULL
disparate	NULL
signalling	NULL
molecules	NULL
are	NULL
integrated	NULL
into	NULL
the	NULL
Cdk-coupled	NULL
Rb-EZF	NULL
mitogenic	NULL
cascade	NULL
represents	NULL
a	NULL
pressing	NULL
challenge	NULL
.	NULL

The	NULL
present	NULL
study	NULL
establishes	NULL
at	NULL
least	NULL
one	NULL
functionally	NULL
important	NULL
link	NULL
between	NULL
cyclin-dependent	NULL
kinases	NULL
and	NULL
Id-bHLH	NULL
regulation	NULL
of	NULL
cell	NULL
cycle	NULL
progression	NULL
,	NULL
which	NULL
also	NULL
impinges	NULL
on	NULL
mechanisms	NULL
underlying	NULL
the	NULL
control	NULL
of	NULL
differentiation	NULL
in	NULL
the	NULL
determination	NULL
of	NULL
cell	NULL
fate	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
C.	NULL
Murre	NULL
,	NULL
X.	NULL
H.	NULL
Sun	NULL
,	NULL
and	NULL
A.	NULL
Fujisawa-Schara	NULL
for	NULL
the	NULL
E12	NULL
,	NULL
E47	NULL
,	NULL
and	NULL
MyoD	NULL
cDNA	NULL
clones	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
U.K.	NULL
Cancer	NULL
Research	NULL
Campaign	NULL
and	NULL
the	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Atherton	NULL
,	NULL
G.	NULL
T.	NULL
,	NULL
H.	NULL
Travers	NULL
,	NULL
R.	NULL
W.	NULL
Deed	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Norton	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
cell	NULL
differentiation	NULL
in	NULL
CC	NULL
;	NULL
,	NULL
myoblasts	NULL
by	NULL
the	NULL
Id3	NULL
helix-loop-helix	NULL
protein	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

7:1059-1066	NULL
.	NULL

2	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
R.	NULL
Maandag	NULL
,	NULL
D.	NULL
J.	NULL
Izon	NULL
,	NULL
D.	NULL
Amsen	NULL
,	NULL
A.	NULL
M.	NULL
Kruisbeek	NULL
,	NULL
B.	NULL
C.	NULL
Weintraub	NULL
,	NULL
I.	NULL
Krop	NULL
,	NULL
M.	NULL
S.	NULL
Schlissel	NULL
,	NULL
A.	NULL
J.	NULL
Feeney	NULL
,	NULL
M.	NULL
van	NULL
Roon	NULL
,	NULL
M.	NULL
van	NULL
der	NULL
Valk	NULL
,	NULL
H.	NULL
te	NULL
Reile	NULL
,	NULL
A.	NULL
Berns	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1994	NULL
.	NULL

E2A	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
initiation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
rear-rangements	NULL
.	NULL

Cell	NULL
79:885-892	NULL
.	NULL

3	NULL
.	NULL

Baker	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
E.	NULL
P.	NULL
Reddy	NULL
.	NULL

1995	NULL
.	NULL

B	NULL
cell	NULL
differentiation	NULL
:	NULL
role	NULL
of	NULL
E2A	NULL
and	NULL
Pax5/BSAP	NULL
transcription	NULL
factors	NULL
.	NULL

Oncogene	NULL
11:413-426	NULL
.	NULL

4	NULL
.	NULL

Barone	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
R.	NULL
Pepperkok	NULL
,	NULL
F.	NULL
A.	NULL
Peverali	NULL
,	NULL
and	NULL
L.	NULL
Philipson	NULL
.	NULL

1994	NULL
.	NULL

Id	NULL
proteins	NULL
control	NULL
growth	NULL
induction	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:4985-4988	NULL
.	NULL

5	NULL
.	NULL

Bartek	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
Bartkova	NULL
,	NULL
and	NULL
J.	NULL
Lukas	NULL
,	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
retinoblastoma	NULL
protein	NULL
pathway	NULL
and	NULL
the	NULL
restriction	NULL
point	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

8:805-814	NULL
.	NULL

6	NULL
.	NULL

Benezra	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
L.	NULL
Davis	NULL
,	NULL
D.	NULL
Lockshon	NULL
,	NULL
D.	NULL
L.	NULL
Turner	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
protein	NULL
Id	NULL
:	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
helix-loop-helix	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Cell	NULL
61:49-59	NULL
.	NULL

7	NULL
.	NULL

Crescenzi	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
P.	NULL
Fleming	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Lassar	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1990	NULL
.	NULL

MyoD	NULL
induces	NULL
growth	NULL
arrest	NULL
independent	NULL
of	NULL
differentiation	NULL
in	NULL
normal	NULL
and	NULL
transformed	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:8442-8446	NULL
.	NULL

8	NULL
.	NULL

Deed	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
S.	NULL
Armitage	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Norton	NULL
.	NULL

1996	NULL
.	NULL

Nuclear	NULL
localization	NULL
and	NULL
regulation	NULL
of	NULL
Id	NULL
protein	NULL
through	NULL
an	NULL
E	NULL
protein-mediated	NULL
chaperone	NULL
mecha-nism	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:23603-23606	NULL
.	NULL

9	NULL
.	NULL

Deed	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
S.	NULL
M.	NULL
Bianchi	NULL
,	NULL
G.	NULL
T.	NULL
Atherton	NULL
,	NULL
D.	NULL
Johnston	NULL
,	NULL
M.	NULL
Santibanez-Koref	NULL
,	NULL
J.	NULL
J.	NULL
Murphy	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Norton	NULL
.	NULL

1993	NULL
.	NULL

An	NULL
immediate	NULL
early	NULL
human	NULL
gene	NULL
encodes	NULL
an	NULL
Id-like	NULL
helix-loop-helix	NULL
protein	NULL
and	NULL
is	NULL
regulated	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
in	NULL
diverse	NULL
cell	NULL
types	NULL
.	NULL

Oncogene	NULL
8:599-607	NULL
.	NULL

10	NULL
.	NULL

Desprez	NULL
,	NULL
P.-Y	NULL
.	NULL

,	NULL
E.	NULL
Hara	NULL
,	NULL
M.	NULL
J.	NULL
Bissel	NULL
,	NULL
and	NULL
J.	NULL
Campisi	NULL
.	NULL

1995	NULL
.	NULL

Suppression	NULL
of	NULL
mammary	NULL
epithelial	NULL
cell	NULL
differentiation	NULL
by	NULL
the	NULL
helix-loop-helix	NULL
protein	NULL
Id1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3398-3404	NULL
.	NULL

11	NULL
.	NULL

Evan	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
L.	NULL
Brown	NULL
,	NULL
M.	NULL
Whyte	NULL
,	NULL
and	NULL
E.	NULL
Harrington	NULL
.	NULL

1995	NULL
.	NULL

Apoptosis	NULL
and	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

7:825-834	NULL
.	NULL

12	NULL
.	NULL

Hara	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Hall	NULL
,	NULL
and	NULL
G.	NULL
Peters	NULL
.	NULL

1997	NULL
.	NULL

Cdk2-dependent	NULL
phosphorylation	NULL
of	NULL
Id2	NULL
modulates	NULL
activity	NULL
of	NULL
E2A-related	NULL
transcription	NULL
factors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16	NULL
:	NULL
332-342	NULL
.	NULL

13	NULL
.	NULL

Hara	NULL
,	NULL
E.	NULL
,	NULL
T.	NULL
Yamaguchi	NULL
,	NULL
H.	NULL
Nojima	NULL
,	NULL
T.	NULL
Ide	NULL
,	NULL
J.	NULL
Campisi	NULL
,	NULL
H.	NULL
Okayama	NULL
,	NULL
and	NULL
K.	NULL
Oda	NULL
.	NULL

1994	NULL
.	NULL

Id-related	NULL
genes	NULL
encoding	NULL
helix-loop-helix	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
G1	NULL
progression	NULL
and	NULL
are	NULL
repressed	NULL
in	NULL
senescent	NULL
human	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:2139-2145	NULL
.	NULL

14	NULL
.	NULL

Henthorn	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Kiledjan	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1990	NULL
.	NULL

Two	NULL
distinct	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
uES/KE2	NULL
motif	NULL
.	NULL

Science	NULL
247:467-470	NULL
.	NULL

15	NULL
.	NULL

Iavarone	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Garg	NULL
,	NULL
A.	NULL
Lasorella	NULL
,	NULL
J.	NULL
Hsu	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Israel	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
helix-loop-helix	NULL
protein	NULL
Id-2	NULL
enhances	NULL
cell	NULL
proliferation	NULL
and	NULL
binds	NULL
to	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:1270-1284	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

CELL	NULL
CYCLE	NULL
PHOSPHORYLATION	NULL
OF	NULL
Id3	NULL
-	NULL
6821	NULL
Jacks	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Weinberg	NULL
.	NULL

1996	NULL
.	NULL

Cell	NULL
cycle	NULL
control	NULL
and	NULL
its	NULL
watchman	NULL
.	NULL

Nature	NULL
381:643-644	NULL
.	NULL

Jen	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Weintraub	NULL
,	NULL
and	NULL
R.	NULL
Benezra	NULL
.	NULL

1992	NULL
.	NULL

Overexpression	NULL
of	NULL
Id	NULL
protein	NULL
inhibits	NULL
the	NULL
muscle	NULL
differentiation	NULL
program	NULL
:	NULL
in	NULL
vivo	NULL
association	NULL
of	NULL
Id	NULL
with	NULL
E2A	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1466-1479	NULL
.	NULL

Kadesch	NULL
,	NULL
T.	NULL
1993	NULL
.	NULL

Consequences	NULL
of	NULL
heteromeric	NULL
interactions	NULL
among	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

449-55	NULL
.	NULL

Kamb	NULL
,	NULL
A	NULL
.	NULL

1995	NULL
.	NULL

Cell-cycle	NULL
regulators	NULL
and	NULL
cancer	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

11:136-140	NULL
.	NULL

Kato	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Matsushime	NULL
,	NULL
S.	NULL
Hiebert	NULL
,	NULL
M.	NULL
E.	NULL
Ewen	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Sherr	NULL
.	NULL

1993	NULL
.	NULL

Direct	NULL
binding	NULL
of	NULL
cyclin	NULL
D	NULL
to	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
(	NULL
pRb	NULL
)	NULL
and	NULL
pRb	NULL
phosphorylation	NULL
by	NULL
the	NULL
cyclin	NULL
D-dependent	NULL
kinase	NULL
CDK-4	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:331-342	NULL
.	NULL

Lam	NULL
,	NULL
E.	NULL
W.	NULL
F.	NULL
,	NULL
and	NULL
N.	NULL
B.	NULL
LaThangue	NULL
.	NULL

1994	NULL
.	NULL

Dp	NULL
and	NULL
E2F	NULL
proteins	NULL
:	NULL
coordi-pating	NULL
transcription	NULL
and	NULL
cell	NULL
cycle	NULL
regulation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6:859-866	NULL
.	NULL

Lassar	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
R.	NULL
L.	NULL
Davis	NULL
,	NULL
W.	NULL
E.	NULL
Wright	NULL
,	NULL
T.	NULL
Kadesch	NULL
,	NULL
C.	NULL
Murre	NULL
,	NULL
A.	NULL
F.	NULL
Voronova	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
activity	NULL
of	NULL
myogenic	NULL
HLH	NULL
proteins	NULL
requires	NULL
hetero-oligomerization	NULL
with	NULL
E12/E47-like	NULL
proteins	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
66:305-315	NULL
.	NULL

Lee	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
S.	NULL
Hollenberg	NULL
,	NULL
L.	NULL
Snider	NULL
,	NULL
D.	NULL
L.	NULL
Turner	NULL
,	NULL
N.	NULL
Lipnick	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1995	NULL
.	NULL

Conversion	NULL
of	NULL
Xenopus	NULL
ectoderm	NULL
into	NULL
neurons	NULL
by	NULL
Neu-roD	NULL
,	NULL
a	NULL
basic	NULL
helix-loop-helix	NULL
protein	NULL
.	NULL

Science	NULL
268:836-844	NULL
.	NULL

Littlewood	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
and	NULL
G.	NULL
I.	NULL
Evan	NULL
.	NULL

1995	NULL
.	NULL

Transcription	NULL
factors	NULL
2	NULL
:	NULL
helix-loop-helix	NULL
.	NULL

Protein	NULL
Profile	NULL
2:621-702.	NULL
.	NULL

Loveys	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
M.	NULL
B.	NULL
Streiff	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Kato	NULL
.	NULL

1996	NULL
.	NULL

E2A	NULL
basic-helix-loop-helix	NULL
transcription	NULL
factors	NULL
are	NULL
negatively	NULL
regulated	NULL
by	NULL
serum	NULL
growth	NULL
factors	NULL
and	NULL
by	NULL
the	NULL
Id3	NULL
protein	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

24:2813-2820	NULL
.	NULL

Mitsui	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Shirakata	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Paterson	NULL
.	NULL

1993	NULL
.	NULL

Phosphorylation	NULL
inhibits	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
MyoD	NULL
homodimers	NULL
but	NULL
not	NULL
MyoD-E12	NULL
het-crodimers	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:24415-24420	NULL
.	NULL

Muller	NULL
,	NULL
R.	NULL
,	NULL
D.	NULL
Mumberg	NULL
,	NULL
and	NULL
F.	NULL
C.	NULL
Lucibello	NULL
.	NULL

1993	NULL
.	NULL

Signals	NULL
and	NULL
genes	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cell-cycle	NULL
progression	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1155:151-179	NULL
.	NULL

Murphy	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
J.	NULL
S.	NULL
Newton	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Norton	NULL
.	NULL

1997	NULL
.	NULL

Early	NULL
response	NULL
genes	NULL
and	NULL
B	NULL
cell	NULL
activation	NULL
,	NULL
p.	NULL
183-202	NULL
.	NULL

In	NULL
M.	NULL
M.	NULL
Harnett	NULL
and	NULL
K.	NULL
P.	NULL
Righley	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Lymphocyte	NULL
signalling	NULL
:	NULL
mechanisms	NULL
,	NULL
subversion	NULL
and	NULL
manipulation	NULL
.	NULL

John	NULL
Wiley	NULL
and	NULL
Sons	NULL
Ltd.	NULL
,	NULL
Chichester	NULL
,	NULL
United	NULL
Kingdom	NULL
.	NULL

Murphy	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Norton	NULL
.	NULL

1990	NULL
.	NULL

Cell-type-specific	NULL
carly	NULL
response	NULL
gene	NULL
expression	NULL
during	NULL
plasmacytoid	NULL
differentiation	NULL
of	NULL
human	NULL
B	NULL
lymphocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1049:261-271	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
G.	NULL
Bain	NULL
,	NULL
M.	NULL
A.	NULL
Dijk	NULL
,	NULL
I.	NULL
Engel	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Furnari	NULL
,	NULL
M.	NULL
E.	NULL
Massari	NULL
,	NULL
J.	NULL
R.	NULL
Matthews	NULL
,	NULL
M.	NULL
W.	NULL
Quong	NULL
,	NULL
R.	NULL
R.	NULL
Rivera	NULL
,	NULL
and	NULL
M.	NULL
H.	NULL
Stuiver	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1218:129-135	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
S.	NULL
McCaw	NULL
,	NULL
H.	NULL
Vaessin	NULL
,	NULL
M.	NULL
Caudy	NULL
,	NULL
L.	NULL
Y.	NULL
Jan	NULL
,	NULL
Y.	NULL
N.	NULL
Jan	NULL
,	NULL
C.	NULL
V.	NULL
Cabrera	NULL
,	NULL
J.	NULL
N.	NULL
Buskin	NULL
,	NULL
S.	NULL
D.	NULL
Hauschka	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Lassar	NULL
,	NULL
H.	NULL
Weintraub	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

Interactions	NULL
between	NULL
heterologous	NULL
helix-loop-helix	NULL
proteins	NULL
generate	NULL
complexes	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
a	NULL
common	NULL
DNA	NULL
sequence	NULL
.	NULL

Cell	NULL
58:537-544	NULL
.	NULL

Olson	NULL
,	NULL
E.	NULL
N.	NULL
1990	NULL
.	NULL

MyoD	NULL
family	NULL
:	NULL
a	NULL
paradigm	NULL
for	NULL
development	NULL
?	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1454-1461	NULL
.	NULL

Peverali	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
T.	NULL
Ramgqvist	NULL
,	NULL
R.	NULL
Saffrich	NULL
,	NULL
R.	NULL
Pepperkok	NULL
,	NULL
M.	NULL
V.	NULL
Barone	NULL
,	NULL
and	NULL
L.	NULL
Philipson	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
G	NULL
,	NULL
progresion	NULL
by	NULL
E2A	NULL
and	NULL
Id	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4291-4301	NULL
.	NULL

Phillips	NULL
,	NULL
S.	NULL
E.	NULL
V.	NULL
1994	NULL
.	NULL

Built	NULL
by	NULL
association	NULL
:	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
helix-loop-helix	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Structure	NULL
2:1-4	NULL
.	NULL

Robb	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
C.	NULL
G.	NULL
Begley	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
HLH	NULL
gene	NULL
SCL	NULL
implicated	NULL
in	NULL
T	NULL
cell	NULL
ALL	NULL
and	NULL
in	NULL
normal	NULL
development	NULL
.	NULL

Int	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

28:609-618	NULL
.	NULL

Rudnicki	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
R.	NULL
Jaenisch	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
MyoD	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
skeletal	NULL
myogenesis	NULL
.	NULL

Bioessays	NULL
17:203-209	NULL
.	NULL

Shoji	NULL
,	NULL
W.	NULL
,	NULL
T.	NULL
Yamamoto	NULL
,	NULL
and	NULL
M.	NULL
Obinata	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
helix-loop-helix	NULL
protein	NULL
Id	NULL
inhibits	NULL
differentiation	NULL
of	NULL
murine	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:5078-5084	NULL
.	NULL

Sloan	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
P.	NULL
Shen	NULL
,	NULL
R.	NULL
McCarrick-	NULL
Walmsley	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1996	NULL
.	NULL

Phosphorylation	NULL
of	NULL
E47	NULL
as	NULL
a	NULL
potential	NULL
determinant	NULL
of	NULL
B-cell	NULL
specificity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:6900-6908	NULL
.	NULL

Smith	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
K.	NULL
S.	NULL
Johnson	NULL
.	NULL

1988	NULL
.	NULL

Single	NULL
step	NULL
purification	NULL
of	NULL
polypep-tides	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
as	NULL
fusions	NULL
with	NULL
glutathione	NULL
S-transferase	NULL
.	NULL

Gene	NULL
67:31-40	NULL
.	NULL

Sorrentino	NULL
,	NULL
V.	NULL
,	NULL
R.	NULL
Pepperkok	NULL
,	NULL
R.	NULL
L.	NULL
Davis	NULL
,	NULL
W.	NULL
Ansorge	NULL
,	NULL
and	NULL
L.	NULL
Philipson	NULL
.	NULL

1990	NULL
.	NULL

Cell	NULL
proliferation	NULL
inhibited	NULL
by	NULL
MyoD1	NULL
independently	NULL
of	NULL
myogenic	NULL
differentiation	NULL
.	NULL

Nature	NULL
345:813-815	NULL
.	NULL

Sun	NULL
,	NULL
X.-H.	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

Id	NULL
proteins	NULL
Id1	NULL
and	NULL
Id2	NULL
selectively	NULL
inhibit	NULL
DNA	NULL
binding	NULL
by	NULL
one	NULL
class	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5603-5611	NULL
.	NULL

Weintraub	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
L.	NULL
Davis	NULL
,	NULL
M.	NULL
Tapscott	NULL
,	NULL
M.	NULL
Thayer	NULL
,	NULL
M.	NULL
Krause	NULL
,	NULL
R.	NULL
Benezra	NULL
,	NULL
D.	NULL
Blackwell	NULL
,	NULL
R.	NULL
Turner	NULL
,	NULL
P.	NULL
Rupp	NULL
,	NULL
S.	NULL
Hollenberg	NULL
,	NULL
Y.	NULL
Zhuang	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Lassar	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
MyoD	NULL
gene	NULL
family	NULL
:	NULL
nodal	NULL
point	NULL
during	NULL
specification	NULL
of	NULL
the	NULL
muscle	NULL
cell	NULL
lincage	NULL
.	NULL

Science	NULL
251:761-766	NULL
.	NULL

Wibley	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
W.	NULL
Deed	NULL
,	NULL
M.	NULL
Jasiok	NULL
,	NULL
K.	NULL
Douglas	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Norton	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
homology	NULL
model	NULL
of	NULL
the	NULL
Id2	NULL
helix-loop-helix	NULL
domain	NULL
as	NULL
a	NULL
basis	NULL
for	NULL
structure-function	NULL
predictions	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1294:138-146	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
Cheng	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1996	NULL
.	NULL

B-lymphocyte	NULL
development	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
combined	NULL
dosage	NULL
of	NULL
three	NULL
basic	NULL
helix-loop-helix	NULL
genes	NULL
,	NULL
E2A	NULL
,	NULL
E2-2	NULL
,	NULL
and	NULL
HEB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2898-2905	NULL
.	NULL

